<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Guy Rordorf, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Colin McDonald, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Scott E Kasner, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan A Edlow, MD, FACEP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alejandro A Rabinstein, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Glenn A Tung, MD, FACR</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard P Goddeau, Jr, DO, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 11, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1134198724"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Intracerebral hemorrhage (ICH) is the second most common cause of stroke after ischemic stroke and is a substantial cause of morbidity and mortality.</p><p>ICH may be categorized as either spontaneous or traumatic. ICH following traumatic brain injury is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/4825.html" rel="external">"Traumatic brain injury: Epidemiology, classification, and pathophysiology", section on 'Primary brain injury'</a>.)</p><p>The pathogenesis, epidemiology, clinical features, and diagnosis of spontaneous (atraumatic) ICH will be reviewed here. Other aspects of ICH are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/129071.html" rel="external">"Spontaneous intracerebral hemorrhage: Secondary prevention and long-term prognosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/107995.html" rel="external">"Hemorrhagic stroke in children"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/114253.html" rel="external">"Stroke in the newborn: Management and prognosis"</a>.)</p><p></p><p class="headingAnchor" id="H3184078197"><span class="h1">PATHOGENESIS AND ETIOLOGIES</span></p><p class="headingAnchor" id="H1864931509"><span class="h2">Mechanisms of brain injury</span><span class="headingEndMark"> — </span>There are several mechanisms of brain injury in ICH. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Primary mechanical injury to brain parenchyma occurs via hematoma expansion and perilesional edema. Both hematoma volume and edema contribute to the mass effect and increased intracranial pressure (ICP), which in turn can cause reduced cerebral perfusion and ischemic injury, and, in very large ICH, cerebral herniation [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Secondary brain injury from the breakdown of the blood-brain barrier after the initial hemorrhage includes excitotoxic and inflammatory processes; however, the exact mechanism(s) underlying this remain uncertain.</p><p></p><p>Enlargement of the hemorrhage is associated with neurologic deterioration, the development of increased intracranial pressure, and worse outcomes. In most cases, the bulk of hemorrhage expansion occurs in the first several hours after onset of ICH [<a href="#rid2">2-5</a>].</p><p>Perihematomal edema is frequent in ICH and may be related to mass effect, local neuronal ischemia, or the accumulation of cytotoxic factors [<a href="#rid6">6</a>]. Edema is present on computed tomography (CT) or magnetic resonance imaging (MRI) in at least half of patients when the patient is first imaged and progresses, reaching maximum volume 7 to 12 days after onset; the most rapid expansion occurs in the first 48 hours [<a href="#rid7">7-9</a>]. Hemorrhage volume, higher admission hematocrit, and a prolonged partial thromboplastin time appear to correlate with peak edema volume.</p><p>The perihematomal region exhibits delayed perfusion and increased diffusivity mixed with areas of reduced diffusion, suggesting the presence of both vasogenic and cytotoxic (ischemic) edema [<a href="#rid10">10</a>]. Acute blood pressure changes with impaired cerebral autoregulation in patients with ICH may contribute to perihematomal ischemia [<a href="#rid11">11</a>]. Underlying hypertensive vasculopathy or cerebral amyloid angiopathy (CAA) may also affect autoregulation in some patients. Increased intracranial pressure and the resulting reduction in cerebral perfusion pressure may play a role; this phenomenon may be exacerbated by blood pressure lowering.</p><p>Breakdown of the blood-brain barrier due to an inflammatory response to the ICH may be identified by contrast enhancement of brain tissue. In patients with acute and subacute ICH, postcontrast enhancement may be noted in the perihematomal area on CT and MRI [<a href="#rid12">12,13</a>]. Contrast enhancement remote from the hematoma may also be identified on imaging. One MRI study described a pattern of punctate areas of contrast enhancement in the sulcal areas both contiguous and remote from the hemorrhage suggesting that acute ICH may be associated with a more diffuse inflammatory process leading to widespread breakdown of the blood-brain barrier [<a href="#rid14">14</a>].</p><p>MRI hyperintensities on diffusion-weighted imaging (DWI) may also be seen with ICH. In some cases, restricted diffusion adjacent to the acute hematoma may be due to distortion of the magnetic field from paramagnetic blood products [<a href="#rid15">15</a>]. However, acute ischemic lesions discontiguous with the hemorrhage may also be identified on DWI [<a href="#rid16">16-19</a>]. In a 2019 meta-analysis of 11 studies and 1910 patients with ICH, the prevalence of diffusion lesions was approximately 20 percent and did not differ between ICH related to hypertensive vasculopathy or ICH related to CAA [<a href="#rid20">20</a>]. The mechanism causing this phenomenon and the implication of these findings for clinical brain injury and prognosis are as yet undefined [<a href="#rid21">21</a>]. One study with follow-up imaging identified new ischemic lesions beyond the acute ICH period [<a href="#rid19">19</a>].</p><p class="headingAnchor" id="H2862611294"><span class="h2">Specific etiologies</span><span class="headingEndMark"> — </span>There are several underlying pathological conditions associated with ICH; hypertension, amyloid angiopathy, and ruptured vascular malformation are most common [<a href="#rid22">22,23</a>].</p><p class="headingAnchor" id="H2117245430"><span class="h3">Hypertensive vasculopathy</span><span class="headingEndMark"> — </span>Hypertensive hemorrhages occur in the territory of penetrator arteries that branch off major intracerebral arteries, often at 90 degree angles to the parent vessel  (<a class="graphic graphic_diagnosticimage graphicRef118071" href="/z/d/graphic/118071.html" rel="external">image 1</a>). These small penetrating arteries may be particularly susceptible to the effects of hypertension, as they are directly exposed to the pressure of the much larger parent vessel, without the protection of a preceding gradual decrease in vessel caliber [<a href="#rid24">24</a>].</p><p>The blood vessels that give rise to hypertensive hemorrhage are generally the same as those affected by hypertensive occlusive disease and diabetic vasculopathy, which cause lacunar strokes. These vessels supply the pons and midbrain (penetrators branching from the basilar artery), thalamus (thalamostriate and thalamogeniculate penetrators branching from the P1 and P2 segments of the posterior cerebral arteries), putamen, caudate, and globus pallidus (lenticulostriate penetrators branching from the M1 segment of the middle cerebral artery), and cerebellar nuclei (dentate nucleus penetrators branching from the cerebellar arteries). Cerebellar hemorrhage is more common than lacunar infarction in the cerebellum. Hypertensive vasculopathy is also believed to play a role in the development of white matter small vessel disease (leukoaraiosis), which may account for the association between white matter disease and risk of ICH [<a href="#rid25">25</a>].</p><p>Pathologic examination of the blood vessels in patients with chronic hypertension and in those with ICH has led to a theory of how hypertensive hemorrhage occurs. The penetrator vessels in patients with chronic hypertension develop intimal hyperplasia with hyalinosis in the vessel wall; this predisposes to focal necrosis, causing injury to the wall of the vessel. These microscopic "pseudoaneurysms" have been associated with small amounts of blood identified in the extravascular space. Pseudoaneurysm formation with subclinical leaks of blood may be relatively common; massive hemorrhage can occur when the clotting system is unable to compensate for these disruptions in the vessel wall.</p><p>Cerebral microbleeds (CMBs) are markers of bleeding-prone microangiopathy that may be found on imaging of patients with ICH due to hypertensive vasculopathy. T2*-weighted gradient echo and susceptibility-weighted MRI sequences can detect CMBs as punctate foci of hemosiderin deposition that represent remnants of clinically silent cerebral microhemorrhage [<a href="#rid26">26,27</a>]. The anatomic distribution of microbleeds varies with their etiology, with hypertensive microbleeds arising in the basal ganglia, thalamus, pons, and cerebellar nuclei in contrast with CAA-related microbleeds, which are found in more superficial lobar regions of the cerebral hemispheres  (<a class="graphic graphic_diagnosticimage graphicRef132282" href="/z/d/graphic/132282.html" rel="external">image 2</a>). This regional distribution is consistent with the usual location of ICH in these conditions.</p><p class="headingAnchor" id="H830874206"><span class="h3">Cerebral amyloid angiopathy</span><span class="headingEndMark"> — </span>CAA is an important cause of primary lobar ICH in older adults. CAA is characterized by the deposition of congophilic material in small- to medium-sized blood vessels of the brain and leptomeninges. This weakens the structure of the vessel walls and makes them prone to bleeding. CAA usually manifests with spontaneous lobar hemorrhage  (<a class="graphic graphic_diagnosticimage graphicRef50480" href="/z/d/graphic/50480.html" rel="external">image 3</a>). The presence of CMBs restricted to the lobar region is associated with CAA. CAA is described in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1128.html" rel="external">"Cerebral amyloid angiopathy"</a>.)</p><p class="headingAnchor" id="H2681079988"><span class="h3">Other etiologies</span><span class="headingEndMark"> — </span>Several other less common underlying etiologies of nontraumatic ICH include [<a href="#rid23">23,28-32</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arteriovenous and other vascular malformations</strong> – Rupture of vascular malformations including arteriovenous malformations (AVMs) and cavernous malformations (CMs) may be the cause of ICH. AVMs are characterized by connection of high-flow arterial pressure to the venous circulation without intervening capillary network. The hemorrhage is thought to result from rupture of a weakened vascular segment such as an intranidal aneurysm and most frequently occurs in lobar, intraventricular, or subarachnoid regions  (<a class="graphic graphic_diagnosticimage graphicRef53992" href="/z/d/graphic/53992.html" rel="external">image 4</a> and <a class="graphic graphic_diagnosticimage graphicRef132273" href="/z/d/graphic/132273.html" rel="external">image 5</a>). Perilesional brain ischemia from vascular steal may also occur in patients with AVMs. By contrast, the hemorrhage due to spontaneous rupture of a CM is less common than with AVMs because these lesions are slow-flow vascular malformations comprised of thin-walled capillaries. ICH due to CMs commonly occurs in the brainstem, juxtacortical regions, or intraventricular space. (See  <a class="medical medical_review" href="/z/d/html/1087.html" rel="external">"Brain arteriovenous malformations", section on 'Pathogenesis and pathology'</a> and  <a class="medical medical_review" href="/z/d/html/1129.html" rel="external">"Vascular malformations of the central nervous system", section on 'Cavernous malformations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cerebral venous thrombosis</strong> – Obstruction of the cerebral veins or venous sinuses results in increased venous pressure and leads to venous or capillary rupture with hemorrhage, often with simultaneous venous infarction  (<a class="graphic graphic_diagnosticimage graphicRef132274" href="/z/d/graphic/132274.html" rel="external">image 6</a>). Cerebral venous thrombosis most often occurs in individuals with a prothrombotic state. (See  <a class="medical medical_review" href="/z/d/html/1103.html" rel="external">"Cerebral venous thrombosis: Etiology, clinical features, and diagnosis", section on 'Pathogenesis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemorrhagic infarction</strong> – Breakdown of the structural integrity of the neurovascular unit accompanies tissue death during ischemic infarction. Blood extravasation during acute infarction may be visible on imaging as acute hemorrhagic infarction (or hemorrhagic transformation)  (<a class="graphic graphic_diagnosticimage graphicRef132275" href="/z/d/graphic/132275.html" rel="external">image 7</a>). Hemorrhagic infarction is common in ischemic infarcts that are large or associated with cerebral edema and those from an embolic source. Reperfusion injury after thrombolytic therapy or thrombectomy may also be a source of hemorrhagic infarction. (See  <a class="medical medical_review" href="/z/d/html/14085.html" rel="external">"Pathophysiology of ischemic stroke"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reversible cerebral vasoconstriction syndrome (RCVS)</strong> – The transient multifocal cerebral arterial narrowing frequently seen with RCVS may also be associated with cerebral insults, including ischemic infarction or ICH  (<a class="graphic graphic_diagnosticimage graphicRef109962" href="/z/d/graphic/109962.html" rel="external">image 8</a>). ICH may be accompanied by subarachnoid hemorrhage in patients with RCVS. The typical clinical presentation includes recurrent thunderclap headaches. (See  <a class="medical medical_review" href="/z/d/html/14075.html" rel="external">"Reversible cerebral vasoconstriction syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Primary or metastatic tumor</strong> – Primary brain tumors such as high-grade gliomas and several metastatic brain tumors such as melanoma, choriocarcinoma, and lung, renal cell, and thyroid carcinomas may cause intratumoral hemorrhage, often associated with a large amount of surrounding edema  (<a class="graphic graphic_diagnosticimage graphicRef132284" href="/z/d/graphic/132284.html" rel="external">image 9</a>). (See  <a class="medical medical_review" href="/z/d/html/5180.html" rel="external">"Overview of the clinical features and diagnosis of brain tumors in adults"</a> and  <a class="medical medical_review" href="/z/d/html/5217.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of brain metastases", section on 'Pathogenesis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central nervous system infection</strong> – Bacterial infections may cause brain abscess leading to ICH via mass effect or vessel wall erosion. Hemorrhagic necrosis of brain tissue may also occur with various viral infection (eg, herpes simplex encephalitis). (See  <a class="medical medical_review" href="/z/d/html/1297.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of brain abscess"</a> and  <a class="medical medical_review" href="/z/d/html/1284.html" rel="external">"Viral encephalitis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mycotic intracranial aneurysm</strong> – Cerebral emboli occurring as a complication of infective endocarditis may infect the arterial wall causing weakening and dilation, termed a mycotic aneurysm. They typically occur in distal arterioles and may be more likely to rupture when associated with a low platelet count or acute ischemic embolic stroke. ICH from this source may be intraparenchymal as well as subarachnoid  (<a class="graphic graphic_diagnosticimage graphicRef132276" href="/z/d/graphic/132276.html" rel="external">image 10</a>). (See  <a class="medical medical_review" href="/z/d/html/2142.html" rel="external">"Complications and outcome of infective endocarditis", section on 'Neurologic complications'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Moyamoya disease</strong> – Progressive arterial narrowing and prominent collateral vessel formation around the circle of Willis in patients with moyamoya disease  (<a class="graphic graphic_diagnosticimage graphicRef129107" href="/z/d/graphic/129107.html" rel="external">image 11</a> and <a class="graphic graphic_diagnosticimage graphicRef129102" href="/z/d/graphic/129102.html" rel="external">image 12</a>) can lead to ICH with or without subarachnoid hemorrhage. Hemorrhage frequently involves the basal ganglia, thalamus, and/or ventricular system  (<a class="graphic graphic_diagnosticimage graphicRef132277" href="/z/d/graphic/132277.html" rel="external">image 13</a>). ICH from moyamoya disease is more common in adults than children and more frequent in the carotid than vertebrobasilar arterial territories. (See  <a class="medical medical_review" href="/z/d/html/1131.html" rel="external">"Moyamoya disease and moyamoya syndrome: Etiology, clinical features, and diagnosis", section on 'Intracerebral, intraventricular, and subarachnoid hemorrhage'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cerebral vasculitis</strong> – Multiple abnormalities on brain MRI may be found in patients with primary central nervous system or systemic vasculitides including T2 hyperintensities, ischemic infarcts, and hemorrhage. Vascular imaging frequently features multifocal segmental narrowing of inflamed blood vessels. (See  <a class="medical medical_review" href="/z/d/html/8230.html" rel="external">"Primary angiitis of the central nervous system in adults"</a> and  <a class="medical medical_review" href="/z/d/html/8226.html" rel="external">"Overview of and approach to the vasculitides in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cerebral hyperperfusion syndrome</strong> – After carotid revascularization procedures, the previously hypoperfused tissue may be unable to accommodate initially to the significant increase in cerebral perfusion pressure. Ipsilateral cerebral edema and hemorrhage typically occur within the first week after revascularization; elevated post-procedural blood pressure is an associated risk factor. (See  <a class="medical medical_review" href="/z/d/html/15843.html" rel="external">"Complications of carotid endarterectomy", section on 'Hyperperfusion syndrome'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sickle cell disease</strong> – Arterial wall thickening and progressive fragility as well as impaired cerebrovascular autoregulation can lead to ICH in patients with sickle cell disease (SCD). The vasculopathy with SCD is also associated with the development of moyamoya syndrome or cerebral aneurysms. ICH in patients with SCD is more common in adults than children and more frequent in those with coexisting hypertension or coagulopathy. (See  <a class="medical medical_review" href="/z/d/html/106228.html" rel="external">"Prevention of stroke (initial or recurrent) in sickle cell disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bleeding disorders</strong> – Acquired or genetic bleeding disorders and conditions that impair hemostasis such as liver disease, antithrombotic therapy, or thrombolytic therapy are risk factors for ICH or systemic hemorrhage but may also be identified as the underlying cause when coagulopathy is severe and when evaluation excludes other sources. (See  <a class="medical medical_review" href="/z/d/html/1326.html" rel="external">"Thrombotic and hemorrhagic disorders due to abnormal fibrinolysis"</a> and  <a class="medical medical_review" href="/z/d/html/13932.html" rel="external">"Hemostatic abnormalities in patients with liver disease"</a> and  <a class="medical medical_review" href="/z/d/html/16134.html" rel="external">"Intravenous thrombolytic therapy for acute ischemic stroke: Therapeutic use", section on 'Intracerebral hemorrhage'</a>.)</p><p></p><p class="headingAnchor" id="H7"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Spontaneous (atraumatic) ICH is the cause of 9 to 27 percent of all strokes globally [<a href="#rid33">33,34</a>]. The overall incidence of ICH ranges from 12 to 31 per 100,000 people and varies by race [<a href="#rid35">35-40</a>]. The incidence of ICH increases with age, doubling every 10 years after age 35 [<a href="#rid41">41,42</a>].</p><p>A 2013 systematic review found that the global burden of brain hemorrhage (mainly ICH but also subarachnoid hemorrhage) was greater than that of ischemic stroke in terms of death and disability, even though the incidence of ischemic stroke was twice as great [<a href="#rid43">43</a>]. The highest incidence of brain hemorrhage was found in Asia and southern sub-Saharan Africa, while the lowest incidence was found in North America, western Europe, Latin America, and Oceana.</p><p>In the United States, ICH incidence varies by race. The rate of occurrence is highest in Chinese and Japanese patients, intermediate in Black Americans, and lowest in White Americans. The higher rate of ICH in Black compared with White Americans is predominately attributable to excess ICH in deep cerebral and brainstem locations where hypertension is the major risk factor [<a href="#rid37">37</a>]. Mexican Americans also have a higher incidence of ICH than non-Hispanic White Americans [<a href="#rid44">44,45</a>].</p><p>Data about the association of sex with the incidence of ICH are inconclusive [<a href="#rid46">46</a>]. A 2010 systematic review and meta-analysis found no significant difference in incidence between male and female patients [<a href="#rid39">39</a>], while a 2009 systematic review found that the incidence of ICH was higher in males [<a href="#rid47">47</a>].</p><p class="headingAnchor" id="H8"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>Major risk factors for spontaneous ICH include older age, hypertension, and the use of antithrombotic (antiplatelet and anticoagulant) therapy.</p><p class="headingAnchor" id="H4262384736"><span class="h2">Age</span><span class="headingEndMark"> — </span>The risk of ICH increases with advancing age. A meta-analysis of more than 8100 patients with ICH assessed the age-related incidence of ICH over a 28-year period [<a href="#rid39">39</a>]. Using the age group of 45 to 54 years as reference, the incidence ratio increased from 0.10 (95% CI 0.06-0.14) for those under 45 years up to 9.6 (95% CI 6.6-13.9) for patients older than 85 years. </p><p class="headingAnchor" id="H808899517"><span class="h2">Hypertension</span><span class="headingEndMark"> — </span>In addition to being the most common etiology of spontaneous ICH (see <a class="local">'Hypertensive vasculopathy'</a> above), hypertension is the most important risk factor for the development of ICH [<a href="#rid40">40,48-51</a>]. Hypertension more than doubles the risk of ICH [<a href="#rid52">52-55</a>].</p><p>The relative contribution of hypertension may be greater for deep than for lobar ICH [<a href="#rid51">51,52,55,56</a>]. In a meta-analysis that pooled data from 28 studies, hypertension was twice as common in patients with deep ICH as in patients with lobar ICH (odds ratio [OR] 2.1, 95% CI 1.82-2.42) [<a href="#rid56">56</a>]. In data from a subset of three studies in the meta-analysis meeting more rigorous methodologic criteria, the association of hypertension with deep ICH remained significant (OR 1.5, 95% CI 1.09-2.07).</p><p>In at least some studies, hypertension has also been shown to be a risk factor for ICH in the setting of other underlying etiologies for ICH (eg, cerebral amyloid angiopathy, antithrombotic-associated ICH) [<a href="#rid57">57-59</a>]. (See  <a class="medical medical_review" href="/z/d/html/1128.html" rel="external">"Cerebral amyloid angiopathy"</a>.)</p><p class="headingAnchor" id="H431098553"><span class="h2">Antithrombotic medications</span><span class="headingEndMark"> — </span>Anticoagulant therapy, particularly <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">warfarin</a>, is associated with an increased risk of ICH, whereas the risk of ICH with antiplatelet monotherapy appears to be minimal [<a href="#rid60">60</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Warfarin</strong> – Anticoagulation with <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">warfarin</a> increases the risk of ICH two- to five-fold, depending upon the intensity of anticoagulation. This is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/119889.html" rel="external">"Risks and prevention of bleeding with oral anticoagulants", section on 'Risk factors related to the anticoagulant'</a>.)</p><p></p><p class="bulletIndent1">In addition to an increased risk of ICH, retrospective evidence suggests that <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">warfarin</a> therapy with an international normalized ratio (INR) &gt;3 is a risk factor for larger initial hemorrhage volume as well as poorer outcomes after ICH. (See  <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Risk factors for poor outcomes'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Direct oral anticoagulants</strong> – The risk of ICH is approximately 30 to 60 percent lower with the direct oral anticoagulants (DOACs; <a class="drug drug_general" data-topicid="8926" href="/z/d/drug information/8926.html" rel="external">dabigatran</a>, <a class="drug drug_general" data-topicid="85642" href="/z/d/drug information/85642.html" rel="external">apixaban</a>, <a class="drug drug_general" data-topicid="99275" href="/z/d/drug information/99275.html" rel="external">edoxaban</a>, <a class="drug drug_general" data-topicid="9498" href="/z/d/drug information/9498.html" rel="external">rivaroxaban</a>) than with <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">warfarin</a> in patients with nonvalvular atrial fibrillation, even when compared with well-controlled warfarin [<a href="#rid61">61</a>]. (See  <a class="medical medical_review" href="/z/d/html/119889.html" rel="external">"Risks and prevention of bleeding with oral anticoagulants", section on 'Risk factors related to the anticoagulant'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Parenteral anticoagulants</strong> – Heparin products, including unfractionated and low-molecular weight heparins, are associated with an elevated risk of ICH. In general, the risk of bleeding rises with the intensity of anticoagulation, duration of therapy, and associated patient-level risk factors. (See  <a class="medical medical_review" href="/z/d/html/1348.html" rel="external">"Heparin and LMW heparin: Dosing and adverse effects", section on 'Bleeding'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thrombolytic agents</strong> – The risk of ICH associated with thrombolytic medications such as <a class="drug drug_general" data-topicid="8478" href="/z/d/drug information/8478.html" rel="external">alteplase</a> or <a class="drug drug_general" data-topicid="9955" href="/z/d/drug information/9955.html" rel="external">tenecteplase</a> varies by dosage and indications. As examples, the rate of ICH was 1.3 percent in a trial of patients receiving thrombolysis for myocardial infarction; whereas, for patients with acute brain ischemia receiving thrombolytic therapy for acute ischemic stroke, the rate of symptomatic ICH was 6 percent [<a href="#rid62">62,63</a>]. (See  <a class="medical medical_review" href="/z/d/html/55.html" rel="external">"Acute ST-elevation myocardial infarction: The use of fibrinolytic therapy", section on 'Stroke'</a> and  <a class="medical medical_review" href="/z/d/html/115775.html" rel="external">"Approach to reperfusion therapy for acute ischemic stroke", section on 'Risk of intracerebral hemorrhage'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antiplatelet agents</strong> – There is probably a small absolute increased risk of primary ICH associated with <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> or antiplatelet agent monotherapy, based on meta-analyses of randomized trials [<a href="#rid60">60,64,65</a>], although other case-control studies have not found an increased risk [<a href="#rid66">66,67</a>]. A subsequent review estimated the absolute risk of ICH attributed to the use of aspirin for primary and secondary prevention of coronary heart disease to be 0.2 events per 1000 patient years [<a href="#rid68">68</a>].</p><p></p><p class="bulletIndent1">Dual antiplatelet therapy likely confers a higher risk compared with monotherapy. In a trial of over 7500 patients with atrial fibrillation for whom <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">warfarin</a> therapy was considered unsuitable, antiplatelet therapy with <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> plus <a class="drug drug_general" data-topicid="8921" href="/z/d/drug information/8921.html" rel="external">clopidogrel</a> increased the risk of ICH twofold compared with aspirin alone (0.4 versus 0.2 percent) [<a href="#rid69">69</a>]. However, in another randomized trial of over 4800 adults with minor stroke or transient ischemic attack (TIA), short-term (90-day) treatment with clopidogrel plus aspirin did not increase the risk of ICH compared with aspirin alone [<a href="#rid70">70</a>].</p><p></p><p class="bulletIndent1">Nonsteroidal anti-inflammatory drugs (NSAIDs) do not appear to increase the risk of ICH [<a href="#rid71">71-74</a>].</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="9533" href="/z/d/drug information/9533.html" rel="external">Prasugrel</a> and <a class="drug drug_general" data-topicid="16784" href="/z/d/drug information/16784.html" rel="external">ticagrelor</a> have been associated with higher rates of major bleeding when used during percutaneous coronary intervention procedures in patients with acute coronary syndromes. (See  <a class="medical medical_review" href="/z/d/html/1573.html" rel="external">"Periprocedural bleeding in patients undergoing percutaneous coronary intervention", section on 'Antithrombotic therapy'</a>.)</p><p></p><p class="headingAnchor" id="H504787949"><span class="h2">Other risk factors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obesity and inactivity</strong> – Inactivity and obesity are comorbidities that can lead to increased risk for ICH. In one study including 777 ICH cases and 2083 control subjects, obesity had a small effect on the risk of ICH (OR 1.28, 95% CI 1.03-1.57), mostly through an indirect effect on hypertension [<a href="#rid75">75</a>]. Additionally, obesity is associated with the risk of obstructive sleep apnea, which is related to an increased prevalence of atrial fibrillation, higher use of anticoagulants, and a surge in nocturnal blood pressure [<a href="#rid76">76</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>High alcohol intake</strong> – Heavy alcohol use is associated with an approximately threefold increased risk of ICH [<a href="#rid53">53,55,77</a>]. In a meta-analysis including 11 prospective studies in patients with ICH, heavy alcohol consumption (&gt;4 drinks/day) was associated with risk for ICH (relative risk 1.67, 95% CI 1.25-2.23) [<a href="#rid78">78</a>]. The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study found a similar association (OR 1.77, 95% CI 1.30-2.41) at the threshold of ≥5 drinks per day [<a href="#rid79">79</a>].</p><p></p><p class="bulletIndent1">Heavy alcohol consumption can also contribute to the risk of ICH indirectly due to its contribution to hypertension [<a href="#rid80">80</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Race and ethnicity</strong> – Race appears to be associated with an increased risk of ICH that is age related. Findings from a surveillance study and a prospective cohort have found that the risk factors of race and age appear to interact, such that young (45- to 60-year-old) Black Americans have a higher risk of ICH than White Americans, but this increased risk declines with increasing age [<a href="#rid54">54,81</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lower cholesterol and lower low-density lipoprotein cholesterol</strong> – A systematic review and meta-analysis of 23 prospective studies found low cholesterol was associated with an increased ICH risk [<a href="#rid82">82</a>].</p><p></p><p class="bulletIndent1">However, the available data suggest that treatment with statins does not clearly increase the risk of ICH [<a href="#rid83">83-88</a>]. One meta-analysis of randomized trials did not find a higher risk of ICH in patients on statins (OR 1.08, 95% CI 0.88-1.32) [<a href="#rid85">85</a>]. However, another meta-analysis of randomized trials involving patients treated with high-dose statins did find an increased risk of ICH (risk ratio 1.53, 95% CI 1.16-2.01) [<a href="#rid89">89</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetic variation</strong> – Specific genetic features may contribute to as much as 44 percent of ICH risks [<a href="#rid90">90</a>]. However, most cases of ICH are not believed to have a monogenetic component. One exception is cerebral amyloid angiopathy-related ICH, which has been shown to have an association with apolipoprotein E (APOE) genotype. A large-scale genetic association study of 2189 ICH cases and 4041 controls revealed that the APOE allele epsilon 4 was also associated with deep ICH (OR 1.21), a location not typical for cerebral amyloid angiopathy [<a href="#rid91">91</a>]; however, in another large study, APOE epsilon 2 or epsilon 4 allele was specifically associated with lobar and not deep ICH [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/z/d/html/1128.html" rel="external">"Cerebral amyloid angiopathy", section on 'Genetic susceptibilities'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Small-vessel vascular disease</strong> – Evidence of small-vessel disease may be seen on brain magnetic resonance imaging studies as lacunar infarcts, white matter hyperintensities on T2 sequences, or microbleeds. These markers of blood vessel fragility or atherosclerosis within the small vessels of the brain are associated with an elevated risk of ICH. In an observational study involving nearly 1500 patients with prior ischemic stroke and atrial fibrillation taking anticoagulation, the rate of ICH was higher in those with evidence of small-vessel disease than those without (0.6 versus 0.1 percent/year) [<a href="#rid92">92,93</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tobacco use</strong> – Tobacco use may be associated with the risk of ICH, presumably by contributing to elevated blood pressure secondary to an increase in cardiac output and total peripheral vascular resistance and arterial wall damage, which predispose to rupture of small vessels in the brain. In the Physicians Health Study, active smokers had a relative ICH risk of 2.06 percent (95% CI 1.08-3.96) compared with nonsmokers [<a href="#rid94">94</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stimulant drug use</strong> – The use of stimulant medications has been associated with a risk of ICH due to possible spikes in blood pressure and vasospasm. Appetite suppressant or cough medications that contain sympathomimetic properties such as phenylpropanolamine are associated with an elevated risk of ICH [<a href="#rid95">95</a>]. Likewise, cocaine use has been associated with the risk of incidence ICH. Caffeine-containing medications have also been associated with ICH [<a href="#rid96">96</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infections</strong> – Several infectious pathogens have been associated with the risk of incident ICH. These include HIV [<a href="#rid97">97</a>], hepatitis C virus [<a href="#rid98">98,99</a>], and the varicella-zoster virus [<a href="#rid100">100,101</a>] as well as the spirochete from the <em>Leptospira</em> genus that causes leptospirosis [<a href="#rid102">102</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Less-certain risk factors</strong> – Other risk factors for ICH are supported by observational data, including chronic kidney disease [<a href="#rid103">103-105</a>], diabetes [<a href="#rid106">106</a>], use of selective serotonin reuptake inhibitors [<a href="#rid107">107,108</a>], migraine [<a href="#rid109">109</a>], and systemic amyloidosis [<a href="#rid110">110</a>].</p><p></p><p class="headingAnchor" id="H10"><span class="h1">CLINICAL PRESENTATION</span><span class="headingEndMark"> — </span>The signs and symptoms of ICH vary according to the location and size of the hemorrhage  (<a class="graphic graphic_table graphicRef132288" href="/z/d/graphic/132288.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H1858086009"><span class="h2">Onset and progression</span><span class="headingEndMark"> — </span>In most circumstances, ICH onset occurs during routine activity. However, some hypertensive hemorrhages occur with exertion or intense emotional activity [<a href="#rid111">111</a>].</p><p>The neurologic symptoms and signs may be progressive over minutes or a few hours  (<a class="graphic graphic_figure graphicRef61491" href="/z/d/graphic/61491.html" rel="external">figure 1</a>), in contrast with brain embolism and subarachnoid hemorrhage, where the neurologic symptoms and signs are often maximal at onset. However, some patients with large ICH are obtunded or comatose when first discovered or at first evaluation upon arrival to the emergency department.</p><p>Headache, vomiting, and a decreased level of consciousness may develop if the hemorrhage is large. This symptom complex is typically absent with small hemorrhages. However, headache and vomiting occur in approximately one-half of patients with ICH  (<a class="graphic graphic_figure graphicRef60831" href="/z/d/graphic/60831.html" rel="external">figure 2</a>). Headache may be due to traction on meningeal pain fibers, increased intracranial pressure (ICP), or blood in the cerebrospinal fluid; it is most common with cerebellar and lobar hemorrhages. Patients may complain of a stiff neck and have meningismus on physical examination if there is intraventricular blood.</p><p>Stupor or coma attributed to the ICH is often an ominous sign. Exceptions include patients with thalamic hemorrhage with involvement of the reticular activating system who may recover after acute blood is resorbed and those with acute hydrocephalus who might improve if treated with an external ventricular drain. Patients may also present with stupor or coma due to reversible causes such as acute metabolic derangements or seizure.</p><p class="headingAnchor" id="H11"><span class="h2">Neurologic signs and ICH location</span><span class="headingEndMark"> — </span>Neurologic signs vary depending upon the location of the hemorrhage  (<a class="graphic graphic_diagnosticimage graphicRef118071" href="/z/d/graphic/118071.html" rel="external">image 1</a>). In one study, bleeding involved the putamen in approximately 35 percent of cases, cerebral lobes in 30 percent, cerebellum in 16 percent, thalamus in 15 percent, and pons in 5 to 12 percent [<a href="#rid112">112</a>]. In the subsequent Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT2) of over 2000 subjects with imaging-confirmed ICH and hypertension, the frequency of affected brain structures was as follows [<a href="#rid113">113</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Putamen/globus pallidus – 56 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Posterior limb of internal capsule – 46 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Anterior limb of internal capsule – 5 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Thalamus – 31 percent</p><p class="bulletIndent1"><span class="glyph">●</span>External capsule – 27 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Lobar – 14 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebellum or brainstem – 7 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Caudate head – 2 percent</p><p></p><p>Intraventricular extension of the ICH was identified in 29 percent in this study.</p><p>Neurologic exam deficits typically correspond to the location of the hemorrhage and associated edema. Patients with deficits not attributable to the hemorrhage should be evaluated for other causes, such as expansion of the hemorrhage, post-ictal symptoms after a seizure, or increased intracranial pressure.</p><p>The localization of ICH may be associated with typical neurologic exam findings:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Putaminal hemorrhage</strong> – Spread of hemorrhage into the putamen most commonly occurs along white matter fiber tracts, causing hemiplegia, hemisensory loss, homonymous hemianopsia, and gaze palsy. Stupor and coma may develop if the hemorrhage is large.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Caudate hemorrhage</strong> – Hemorrhage typically originating within the head of the caudate nucleus may cause acute-onset confusion, personality changes, or memory impairment as well as transient contralateral weakness or numbness [<a href="#rid114">114</a>]. Headache and drowsiness may also occur, especially if bleeding extends into the adjacent intraventricular space.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Internal capsule hemorrhage</strong> – Small hemorrhages restricted to the internal capsule may cause mild dysarthria, contralateral hemiparesis, and sensory deficit [<a href="#rid115">115</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cerebellar hemorrhage</strong> – Cerebellar hemorrhage usually originates in the dentate nucleus and may extend into the hemisphere and fourth ventricle and possibly into the pontine tegmentum. These bleeds typically cause an inability to walk due to imbalance, vomiting, and occipital headache. Some patients have referred pain to the neck or shoulder, neck stiffness, gaze palsy, and/or facial weakness. Notably, there is often no hemiparesis. The patient may become stuporous due to obstructive hydrocephalus or brainstem compression.</p><p></p><p class="bulletIndent1">Patients with acute cerebellar hemorrhage may frequently deteriorate and require surgery. (See  <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Surgical approaches for selected patients'</a> and  <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Cerebellar hemorrhage'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thalamic hemorrhage</strong> – Thalamic hemorrhages may extend in a transverse direction to the posterior limb of the internal capsule, downward to put pressure on the tectum of the midbrain, or medially to rupture into the third ventricle. Symptoms include hemiparesis, hemisensory loss, and occasionally transient homonymous hemianopsia. Pupils may be miotic and unreactive along with a gaze palsy (eg, peering at the tip of the nose, skewed, or "wrong-way eyes" toward the weak side [in contrast with hemispheric cortical injury in which the eyes are deviated away from the hemiparesis]). Aphasia may occur if the bleed affects the dominant hemisphere, while neglect may develop if the bleed affects the nondominant hemisphere. Patients with small anterior thalamic hemorrhages may present with drowsiness, acute confusion, or neuropsychiatric symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lobar hemorrhage</strong> – Lobar hemorrhages vary in their neurologic signs depending upon location. They most often affect the parietal and occipital lobes. These bleeds are associated with a higher incidence of seizures. Occipital hemorrhages frequently present with a very dense contralateral homonymous hemianopsia. Hemorrhages in the frontoparietal region will produce a contralateral plegia or paresis of the leg with relative sparing of the arm.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pontine hemorrhage</strong> – Pontine hemorrhages typically originate in brainstem nuclei and may extend into the base of the pons. These often lead to deep coma over the first few minutes following the hemorrhage, probably due to disruption of the reticular activating system. The motor examination may be marked by bilateral paralysis. The pupils are pinpoint and react to a strong light source. Horizontal eye movements are often absent, and there may be ocular bobbing, facial palsy, deafness, and dysarthria if the patient is awake.</p><p></p><p class="headingAnchor" id="H919836714"><span class="h2">Seizures</span><span class="headingEndMark"> — </span>Seizures may accompany acute ICH. Seizures in the first days after ICH occur approximately 15 percent of patients [<a href="#rid116">116,117</a>]; they are more common in lobar hemorrhages (affecting cortical tissue) than in deep or cerebellar ICH [<a href="#rid118">118-121</a>]. (See  <a class="medical medical_review" href="/z/d/html/2220.html" rel="external">"Overview of the management of epilepsy in adults", section on 'Poststroke seizures'</a>.)</p><p class="headingAnchor" id="H314226025"><span class="h2">Cardiac abnormalities</span><span class="headingEndMark"> — </span>Cardiac abnormalities are commonly associated with spontaneous ICH [<a href="#rid122">122</a>]. The most frequently associated electrocardiographic (ECG) changes are prolonged QT interval and ST-T wave changes. These changes may reflect catecholamine-induced cardiac injury, which is most likely due to a centrally mediated release of excess catecholamines caused by increased intracranial pressure or autonomic disturbance [<a href="#rid123">123</a>]. (See  <a class="medical medical_review" href="/z/d/html/3494.html" rel="external">"Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy"</a> and  <a class="medical medical_review" href="/z/d/html/1093.html" rel="external">"Complications of stroke: An overview", section on 'Neurogenic cardiac damage'</a>.)</p><p>Mild elevations in serum myocardial enzymes often accompany the ECG changes, including cardiac troponin and beta natriuretic peptide [<a href="#rid122">122</a>]. Echocardiographic abnormalities may involve global or regional wall motion abnormalities and reduced ejection fraction. Ventricular arrhythmias may occur with brainstem compression [<a href="#rid124">124</a>].</p><p class="headingAnchor" id="H1874658841"><span class="h1">BRAIN IMAGING</span><span class="headingEndMark"> — </span>Both computed tomography (CT) or magnetic resonance imaging (MRI) are considered first-choice imaging options for the emergency diagnosis and assessment of ICH  (<a class="graphic graphic_diagnosticimage graphicRef81767" href="/z/d/graphic/81767.html" rel="external">image 14</a>) [<a href="#rid125">125</a>].</p><p>Clinical deficits on neurologic examination can be correlated with impacted brain regions apparent on CT or MRI. Acute imaging also provides information about extension into the ventricular system, the presence of surrounding edema, shifts in brain contents (herniation), impending expansion, and underlying etiology. ICH severity can be assessed by calculating the volume of the hemorrhage. (See <a class="local">'Estimating hemorrhage volume'</a> below.)</p><p class="headingAnchor" id="H18"><span class="h2">Head CT</span><span class="headingEndMark"> — </span>Noncontrast head computed tomography (CT) accurately identifies the presence of acute ICH, distinguishing it from ischemic stroke. Hyperacute blood will appear hyperdense except in rare cases of severe anemia when it might appear isodense.</p><p>Over weeks, the blood from an acute hemorrhage will typically become isodense and may have a ring-enhancement appearance. Chronically, the blood is hypodense  (<a class="graphic graphic_diagnosticimage graphicRef132278" href="/z/d/graphic/132278.html" rel="external">image 15</a>).</p><p>CT angiography that may be performed along with a noncontrast head CT may identify an underlying vascular cause to the ICH [<a href="#rid29">29,126</a>].</p><p>Noncontrast head CT and CT angiography may also provide additional information regarding propensity for hemorrhagic expansion [<a href="#rid127">127</a>]. (See <a class="local">'Predicting hemorrhage expansion'</a> below.)</p><p class="headingAnchor" id="H19"><span class="h2">Brain MRI</span><span class="headingEndMark"> — </span>Brain magnetic resonance imaging (MRI) is similarly sensitive as CT for detecting acute ICH. Acute ICH can be diagnosed by MRI with up to 100 percent sensitivity and accuracy by experienced readers [<a href="#rid128">128</a>]. In the Hemorrhage and Early MRI Evaluation (HEME) study, 200 patients presenting with focal stroke symptoms were evaluated with MRI including gradient recall echo (GRE) and diffusion-weighted imaging (DWI) sequences within six hours of symptom onset followed by CT [<a href="#rid129">129</a>]. MRI and CT were equivalent for the detection of acute ICH, and MRI was significantly more accurate than CT for the detection of chronic ICH.</p><p>However, MRI is contraindicated for patients with some metallic implants [<a href="#rid130">130</a>]. Additionally, MRIs are not as readily available on an emergent basis as CT and conventional protocols take longer than CT protocols.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Age of hemorrhagic findings</strong> – MRI may also provide information about the age of the ICH  (<a class="graphic graphic_table graphicRef132279" href="/z/d/graphic/132279.html" rel="external">table 2</a>). The appearance of intracerebral blood on MRI images varies with time depending on the paramagnetic properties of the various stages of hemoglobin and on the mode of imaging acquisition [<a href="#rid131">131,132</a>]. Of note, these imaging features do not apply to extra-axial or intraventricular hemorrhage.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hyperacute hemorrhage</strong> <strong>(0 to 3 hours)</strong> − A hyperacute parenchymal hematoma contains oxyhemoglobin and appears hypo- to isointense on T1-weighted images, hyperintense on T2-weighted images, and hypointense on T2*-weighted (GRE or susceptibility-weighted imaging) sequences  (<a class="graphic graphic_diagnosticimage graphicRef81767" href="/z/d/graphic/81767.html" rel="external">image 14</a>) [<a href="#rid133">133</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Acute hemorrhage (3 hours to 3 days)</strong> – Acute ICH can be accurately detected due to the magnetic susceptibility of deoxygenated hemoglobin (deoxyhemoglobin) [<a href="#rid128">128,129,132-136</a>]. This property of superparamagnetic deoxyhemoglobin results in rapid dephasing of proton spins causing signal loss (darkening or hypointensity) that is best seen in T2*-weighted images.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Subacute hemorrhage (3 days to 3 weeks)</strong> – Subacute ICH is recognized by the presence of diamagnetic methemoglobin, which appears as a T1-hyperintense signal, often first along the periphery of the hemorrhage. The appearance on T2-weighted imaging is hypointense in the first week due to magnetic susceptibility but becomes T2 hyperintense in the late subacute stage (one to three weeks) as red blood cells lyse and methemoglobin becomes extracellular.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chronic hemorrhage (&gt;3 weeks)</strong> – The presence of superparamagnetic hemosiderin and ferritin in chronic ICH causes marked hypointensity on T2- and T2*-weighted images. On T1-weighted images, chronic hemorrhage is isointense compared with brain tissue.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonhemorrhagic findings in acute ICH</strong> – Brain MRI may show other findings associated with acute ICH.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cerebral edema</strong> – Tissue damage and subsequent inflammatory response to the presence of intracranial blood can lead to perilesional cerebral edema in ICH [<a href="#rid137">137</a>]. Edema can compress adjacent intracranial structures, causing elevated intracranial pressure (ICP) and leading to hydrocephalus. Cerebral edema may be seen in acute and subacute ICH and typically appears hypointense on T1-weighted images and hyperintense on T2-weighted images.</p><p></p><p class="bulletIndent2">ICH-related cerebral edema often peaks two to three weeks after hemorrhage [<a href="#rid7">7,138</a>]. Acute imaging showing prominent edema along with ICH may indicate subacute age of bleeding or suggest ICH may be due to a specific underlying cause such as cerebral sinus thrombosis  (<a class="graphic graphic_diagnosticimage graphicRef132274" href="/z/d/graphic/132274.html" rel="external">image 6</a>) or tumor  (<a class="graphic graphic_diagnosticimage graphicRef132284" href="/z/d/graphic/132284.html" rel="external">image 9</a>). (See  <a class="medical medical_review" href="/z/d/html/129071.html" rel="external">"Spontaneous intracerebral hemorrhage: Secondary prevention and long-term prognosis", section on 'Follow-up neuroimaging'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diffusion-weighted imaging lesions</strong> – Brain MRI may show hyperintense diffusion-weighted imaging (DWI) lesions associated with acute ICH. These may indicate that the underlying event was a primary ischemic infarct with subsequent hemorrhagic transformation  (<a class="graphic graphic_diagnosticimage graphicRef132275" href="/z/d/graphic/132275.html" rel="external">image 7</a>) or an event that can produce simultaneous ischemic and hemorrhagic injury, such as an embolism from infective endocarditis  (<a class="graphic graphic_table graphicRef132289" href="/z/d/graphic/132289.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/z/d/html/129071.html" rel="external">"Spontaneous intracerebral hemorrhage: Secondary prevention and long-term prognosis", section on 'Follow-up neuroimaging'</a>.)</p><p></p><p class="bulletIndent2">Small DWI hyperintense lesions may also be found in patients with primary acute ICH. These lesions are often punctate in size, multifocal in number, and remote from and contralateral to the site of hemorrhage in location  (<a class="graphic graphic_diagnosticimage graphicRef141459" href="/z/d/graphic/141459.html" rel="external">image 16</a>). They appear to occur most frequently during the first several days after ICH but can also be found on subsequent nonacute imaging [<a href="#rid19">19</a>]. In a systematic review of observational studies that included 5211 patients with acute ICH, the pooled prevalence of DWI lesions on acute brain MRI was 24 percent [<a href="#rid139">139</a>]. DWI lesions are associated with larger ICH volume, subarachnoid bleeding, and elevated blood pressure, suggesting acute changes in cerebral perfusion and/or ICP may contribute to their development [<a href="#rid139">139,140</a>].</p><p></p><p class="bulletIndent1">MRI may also demonstrate imaging findings that may suggest a specific underlying cause. (See <a class="local">'Subsequent imaging'</a> below.)</p><p></p><p class="headingAnchor" id="H2918961938"><span class="h2">Estimating hemorrhage volume</span><span class="headingEndMark"> — </span>An estimate of ICH volume is useful to communicate hemorrhage severity and make early assessments of prognosis. (See  <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Clinical prediction scores'</a>.)</p><p>The formula is calculated using the centimeter scale on the CT (or MRI) images as follows [<a href="#rid141">141</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A is the greatest hemorrhage diameter on the CT slice with the largest area of hemorrhage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>B is the largest diameter 90 degrees to A on the same (index) CT slice  (<a class="graphic graphic_diagnosticimage graphicRef118213" href="/z/d/graphic/118213.html" rel="external">image 17</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>C is the approximate number of CT slices with hemorrhage multiplied by the slice thickness in centimeters. To calculate C, each CT slice with hemorrhage is visually compared with the index CT slice [<a href="#rid141">141</a>]. An individual hemorrhage slice is counted as one full slice for determining C if the hemorrhage area is &gt;75 percent of the area on the slice with the largest hemorrhage. A slice is counted as one-half if the hemorrhage area is approximately 25 to 75 percent of the area on the largest hemorrhage slice. The slice is not counted if the area is &lt;25 percent of the largest hemorrhage slice.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>ABC/2 gives the ICH volume in cubic centimeters.</p><p></p><p>In children, ICH volume may instead be measured as a percent of total brain volume as ABC/XYZ, where X is the largest midline axial diameter of supratentorial brain, Y is the largest axial diameter perpendicular to X, and Z is the brain vertical diameter [<a href="#rid142">142</a>].</p><p class="headingAnchor" id="H718485884"><span class="h2">Predicting hemorrhage expansion</span><span class="headingEndMark"> — </span>Enlargement of the hemorrhage is associated with neurologic deterioration and worse outcomes. These observations indicate that significant improvements in patient outcome from ICH may be achieved by minimizing both secondary brain ischemia and hemorrhage enlargement in the early hours following the onset of bleeding. (See  <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Managing hemorrhagic expansion'</a>.)</p><p>Serial CT scans in patients with hypertensive hemorrhage have shown that the hemorrhage enlarges in the first few hours after presentation in a subset of patients [<a href="#rid2">2,6,143</a>]. In most but not all cases, the bulk of hemorrhage expansion occurs in the first three hours after onset of ICH [<a href="#rid2">2-5,144</a>]. In a prospective series of 103 patients with ICH, significant hemorrhage growth (a &gt;33 percent volume increase) occurred in 38 percent of patients over the first 24 hours [<a href="#rid2">2</a>].</p><p>In a patient-level meta-analysis of studies reporting ICH growth, with data on over 5400 subjects, several independent predictors of hemorrhage growth identified [<a href="#rid145">145</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Shorter time from symptom onset to initial imaging</p><p class="bulletIndent1"><span class="glyph">●</span>ICH volume</p><p class="bulletIndent1"><span class="glyph">●</span>Antiplatelet or anticoagulant use</p><p class="bulletIndent1"><span class="glyph">●</span>Contrast extravasation (eg, "spot sign") on initial CT angiography  (<a class="graphic graphic_diagnosticimage graphicRef118220" href="/z/d/graphic/118220.html" rel="external">image 18</a>)</p><p></p><p>While all patients with ICH should be treated to limit risk for hemorrhage expansion, the presence of specific radiologic findings may trigger a somewhat more aggressive approach to monitoring and treatment. (See <a class="local">'Subsequent imaging'</a> below and  <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spot sign on CT angiography</strong> – The spot sign  (<a class="graphic graphic_diagnosticimage graphicRef118220" href="/z/d/graphic/118220.html" rel="external">image 18</a>) describes the appearance of small focal or multifocal areas of contrast enhancement within a hemorrhage on CT angiography source images [<a href="#rid146">146</a>]. The spot sign has been linked to hemorrhage expansion and poor outcomes, including mortality [<a href="#rid127">127,147</a>]. In a retrospective analysis of 367 patients with acute ICH, a spot sign was found in 19 percent of patients and was independently associated with hemorrhage expansion [<a href="#rid148">148</a>].</p><p></p><p class="bulletIndent1">Accumulation of contrast extravasation within the hemorrhage on postcontrast CT also predicts subsequent hemorrhage expansion [<a href="#rid149">149</a>].</p><p></p><p class="bulletIndent1">Although less well-studied, tiny spots of contrast extravasation within the hemorrhage on MRI (the MRI spot sign) have also been detected on postcontrast T1-weighted and dynamic T1-weighted images, particularly when performed in the first six hours after ICH onset [<a href="#rid150">150</a>]. This "MRI spot sign" may be associated with hematoma growth and worse clinical outcomes, but definitive data are lacking [<a href="#rid151">151</a>].</p><p></p><p class="bulletIndent1">A spot sign score that grades the number of spot signs, their maximum dimension, and attenuation has been found to be a strong predictor of hemorrhage expansion; of these features, the number of spot signs appears to be most predictive [<a href="#rid148">148,152,153</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Signs on noncontrast head CT</strong> – Irregularity or heterogeneity of the hematoma on noncontrast head CT also suggests ongoing bleeding or risk of hematoma expansion [<a href="#rid154">154,155</a>]. In a systematic review including 25 studies and 10,650 patients with ICH, several imaging features visible on CT were associated with subsequent risk of poor functional outcome [<a href="#rid156">156</a>]. These include  (<a class="graphic graphic_diagnosticimage graphicRef132280" href="/z/d/graphic/132280.html" rel="external">image 19</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Irregular hematoma shape</p><p class="bulletIndent2"><span class="glyph">•</span>Island sign (≥3 scattered hematomas separate from the main hematoma)</p><p class="bulletIndent2"><span class="glyph">•</span>Hypodensity (any hypodense focus within the hematoma)</p><p class="bulletIndent2"><span class="glyph">•</span>Heterogeneous density (≥3 foci of hypodensity within the hematoma)</p><p class="bulletIndent2"><span class="glyph">•</span>Black-hole sign (focus of hypodensity with a difference of &gt;28 Hounsfield units [HU] from the hematoma)</p><p class="bulletIndent2"><span class="glyph">•</span>Swirl sign (hypodense region within the hematoma)</p><p class="bulletIndent2"><span class="glyph">•</span>Blend sign (focus of hypodensity with a difference of &gt;18 HU adjacent to the hematoma)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Subarachnoid extension</strong> – In one study, extension of hemorrhage into the subarachnoid space was associated with subsequent hemorrhagic expansion in patients with acute lobar ICH but not in patients with nonlobar ICH [<a href="#rid157">157</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intraventricular extension</strong> – Expansion of ICH into the intraventricular space has been reported in up to 40 to 60 percent of patients in various studies and is associated with neurologic complications and worse outcomes [<a href="#rid158">158-160</a>].</p><p></p><p class="headingAnchor" id="H1463384137"><span class="h1">EVALUATION AND DIAGNOSIS</span><span class="headingEndMark"> — </span>ICH is a neurologic and medical emergency because it is associated with a high risk of ongoing bleeding, progressive neurologic deterioration, permanent disability, and death [<a href="#rid161">161,162</a>].</p><p>As the diagnostic evaluation is proceeding, patients with ICH may also need acute interventions, possibly including intubation and mechanical ventilation, anticoagulation reversal, blood pressure control, intracranial pressure monitoring and treatment, and consideration of the need for ventriculostomy or surgical hematoma evacuation  (<a class="graphic graphic_table graphicRef132288" href="/z/d/graphic/132288.html" rel="external">table 1</a>). These issues are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis"</a>.)</p><p class="headingAnchor" id="H1431780928"><span class="h2">Initial evaluation</span><span class="headingEndMark"> — </span>Clinical suspicion for ICH is based upon features such as acute onset of gradually worsening symptoms and increasing neurologic deficit, particularly if accompanied by severe headache, vomiting, severe hypertension, and decreased level of consciousness or coma. However, the distinction between brain hemorrhage and ischemia cannot be made on the basis of clinical characteristics alone [<a href="#rid162">162</a>]. Importantly, headache may be absent in some cases of ICH. (See <a class="local">'Clinical presentation'</a> above.)</p><p>Neuroimaging with brain computed tomography (CT) or magnetic resonance imaging (MRI) is <strong>mandatory</strong> to confirm the diagnosis of ICH and to exclude ischemic stroke and stroke mimics as possible causes [<a href="#rid162">162</a>].</p><p class="headingAnchor" id="H586581956"><span class="h2">Laboratory and other dignostic testing</span><span class="headingEndMark"> — </span>Routine laboratory evaluation to evaluate for underlying causes or associated risks in patients with ICH includes [<a href="#rid162">162</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Complete blood count, electrolytes, blood urea nitrogen, creatinine, and glucose</p><p class="bulletIndent1"><span class="glyph">●</span>Prothrombin time (with international normalized ratio [INR]) and activated partial thromboplastin time for all patients; thrombin clotting time for patients taking direct oral anticoagulants (and/or ecarin clotting time where available for patients known or suspected to be taking direct thrombin inhibitors)</p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac-specific troponin</p><p class="bulletIndent1"><span class="glyph">●</span>Toxicology screen to detect cocaine and other sympathomimetic drugs</p><p class="bulletIndent1"><span class="glyph">●</span>Urinalysis</p><p class="bulletIndent1"><span class="glyph">●</span>Pregnancy test in a female of childbearing age</p><p></p><p>An electrocardiogram (ECG) obtained at baseline may help identify patients with ICH and coexistent cardiac dysfunction [<a href="#rid163">163,164</a>]. A repeat ECG is also typically obtained along with an echocardiogram for those with heart failure or hemodynamic instability. (See  <a class="medical medical_review" href="/z/d/html/2095.html" rel="external">"Electrocardiogram in the diagnosis of myocardial ischemia and infarction"</a> and  <a class="medical medical_review" href="/z/d/html/3494.html" rel="external">"Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy"</a>.)</p><p>An electroencephalogram is reserved for patients with seizures or those with encephalopathy not explained by the location or size of the ICH. (See  <a class="medical medical_review" href="/z/d/html/14103.html" rel="external">"Nonconvulsive status epilepticus: Classification, clinical features, and diagnosis", section on 'When to suspect NCSE'</a> and <a class="local">'Neurologic signs and ICH location'</a> above.)</p><p class="headingAnchor" id="H24"><span class="h2">Subsequent imaging</span><span class="headingEndMark"> — </span>Once ICH is confirmed by head CT or MRI, additional imaging is warranted in the event of clinical deterioration to evaluate for ICH expansion or rebleeding. A follow-up imaging study may also be performed to document that the bleeding has stabilized.</p><p>Subsequent imaging is also typically performed to identify an underlying cause of the ICH to help guide preventive measures to reduce the risk of recurrent hemorrhage. The necessity for further evaluation to determine the cause of ICH varies with the clinical setting. (See  <a class="medical medical_review" href="/z/d/html/129071.html" rel="external">"Spontaneous intracerebral hemorrhage: Secondary prevention and long-term prognosis", section on 'Follow-up neuroimaging'</a>.)</p><p>For some patients, the etiology of the ICH is identified with initial neuroimaging studies, and further imaging studies are not required. An example may include a stable patient with an acute ICH in the putamen suggestive of hypertensive vasculopathy who has a history of longstanding hypertension.</p><p>For other patients, initial imaging studies do not sufficiently exclude other causes of ICH and follow-up evaluation is required. We obtain follow-up imaging when an underlying cause is suspected by clinical features or initial imaging findings  (<a class="graphic graphic_table graphicRef132289" href="/z/d/graphic/132289.html" rel="external">table 3</a>) [<a href="#rid162">162</a>]. Initial imaging findings that may suggest a specific underlying cause include:</p><p class="bulletIndent2"><span class="glyph">•</span>Early perihematomal edema out of proportion to the underlying ICH  (<a class="graphic graphic_diagnosticimage graphicRef132284" href="/z/d/graphic/132284.html" rel="external">image 9</a>) [<a href="#rid165">165</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>ICH within arterial vascular territory suggesting primary ischemic infarction  (<a class="graphic graphic_diagnosticimage graphicRef132275" href="/z/d/graphic/132275.html" rel="external">image 7</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Multifocal hemorrhage  (<a class="graphic graphic_diagnosticimage graphicRef132287" href="/z/d/graphic/132287.html" rel="external">image 20</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Isolated intraventricular hemorrhage  (<a class="graphic graphic_diagnosticimage graphicRef132281" href="/z/d/graphic/132281.html" rel="external">image 21</a>)</p><p></p><p>The assessment of the possible underlying structural pathology may be shrouded and distorted by the hematoma or surrounding edema. In these cases, delayed imaging performed after bleeding and edema have resolved may identify patients with underlying structural abnormalities at high risk for ICH recurrence  (<a class="graphic graphic_algorithm graphicRef132295" href="/z/d/graphic/132295.html" rel="external">algorithm 1</a>). (See  <a class="medical medical_review" href="/z/d/html/129071.html" rel="external">"Spontaneous intracerebral hemorrhage: Secondary prevention and long-term prognosis", section on 'Follow-up neuroimaging'</a>.)</p><p>Brain MRI with contrast is the preferred modality to help identify the underlying cause of ICH for most patients. For patients who are unable to undergo MRI, head CT with contrast is a less sensitive alternative option. Vascular imaging (eg, CT or MR angiography or digital subtraction angiography) is performed when an underlying vascular lesion is suspected [<a href="#rid29">29,30,126,166</a>]. (See  <a class="medical medical_review" href="/z/d/html/129071.html" rel="external">"Spontaneous intracerebral hemorrhage: Secondary prevention and long-term prognosis", section on 'Follow-up neuroimaging'</a>.)</p><p class="headingAnchor" id="H1708760774"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/105370.html" rel="external">"Society guideline links: Stroke in adults"</a>.)</p><p class="headingAnchor" id="H25"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/16221.html" rel="external">"Patient education: Intracerebral hemorrhage (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/17183.html" rel="external">"Patient education: Arteriovenous malformations in the brain (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/726.html" rel="external">"Patient education: Stroke symptoms and diagnosis (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/724.html" rel="external">"Patient education: Hemorrhagic stroke treatment (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H121289585"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Underlying causes</strong> – Injury to brain parenchyma occurs via hematoma expansion and perilesional edema as well as secondary excitotoxic and inflammatory injury from the breakdown of the blood-brain barrier. Common conditions associated with intracerebral hemorrhage (ICH) include hypertension, cerebral amyloid angiopathy, and ruptured vascular malformation. Other etiologies include cerebral venous thrombosis, vasculopathies, primary or metastatic tumors, and coagulopathies. (See <a class="local">'Pathogenesis and etiologies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Major risk factors for spontaneous ICH include older age, hypertension, and the use of antithrombotic (antiplatelet and anticoagulant) therapy. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presenting signs and symptoms</strong> – The signs and symptoms of ICH vary according to the location and size of the hemorrhage  (<a class="graphic graphic_table graphicRef132288" href="/z/d/graphic/132288.html" rel="external">table 1</a>). Patients typically present with an acute onset of a focal neurologic deficit such as hemiparesis, aphasia, or visual impairment corresponding to the part of the brain affected.</p><p></p><p class="bulletIndent1">The neurologic symptoms and signs may be progressive over minutes or a few hours  (<a class="graphic graphic_figure graphicRef61491" href="/z/d/graphic/61491.html" rel="external">figure 1</a>). Headache, vomiting, and a decreased level of consciousness develop if the hemorrhage is large. Patients may also present with stupor or coma due to associated reversible causes such as acute metabolic derangements or seizure. (See <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial diagnostic imaging</strong> – Neuroimaging with head computed tomography (CT) or magnetic resonance imaging (MRI) is <strong>mandatory</strong> to confirm the diagnosis of ICH and to exclude ischemic stroke and stroke mimics as alternative causes to symptoms. Acute imaging also provides information about the severity of the hemorrhage, the risk of expansion of bleeding, and the underlying cause of the ICH  (<a class="graphic graphic_diagnosticimage graphicRef132280" href="/z/d/graphic/132280.html" rel="external">image 19</a> and <a class="graphic graphic_table graphicRef132289" href="/z/d/graphic/132289.html" rel="external">table 3</a>). (See <a class="local">'Evaluation and diagnosis'</a> above and <a class="local">'Brain imaging'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Both CT or MRI are considered first-choice imaging options for the emergency diagnosis and assessment of ICH. CT angiography may be performed along with a noncontrast head CT to help identify an underlying vascular cause to the ICH. (See <a class="local">'Brain imaging'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Predictors of hemorrhage growth associated with neurologic deterioration include a shorter time from symptom onset to initial imaging, initial ICH volume, antithrombotic medication use, and imaging signs of ICH heterogeneity on noncontrast CT or focal contrast extravasation on CT angiography  (<a class="graphic graphic_diagnosticimage graphicRef118220" href="/z/d/graphic/118220.html" rel="external">image 18</a> and <a class="graphic graphic_diagnosticimage graphicRef132280" href="/z/d/graphic/132280.html" rel="external">image 19</a>). (See <a class="local">'Predicting hemorrhage expansion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Subsequent imaging evaluation</strong> – Additional imaging may be warranted after the diagnosis of ICH in the event of clinical deterioration to evaluate for ICH expansion or rebleeding and to document that the bleeding has stabilized. (See <a class="local">'Subsequent imaging'</a> above.)</p><p></p><p class="bulletIndent1">We also obtain follow-up imaging when an underlying cause is suspected by clinical features or initial imaging findings to help guide preventive measures to reduce the risk of recurrent hemorrhage  (<a class="graphic graphic_table graphicRef132289" href="/z/d/graphic/132289.html" rel="external">table 3</a>). Brain MRI with contrast is the preferred modality to help identify the underlying cause of ICH for most patients. Vascular imaging (eg, CT or MR angiography or digital subtraction angiography) is performed when an underlying vascular lesion is suspected. (See <a class="local">'Subsequent imaging'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Xu BN, Yabuki A, Mishina H, et al. Pathophysiology of brain swelling after acute experimental brain compression and decompression. Neurosurgery 1993; 32:289.</a></li><li><a class="nounderline abstract_t">Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28:1.</a></li><li><a class="nounderline abstract_t">Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352:777.</a></li><li><a class="nounderline abstract_t">Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006; 66:1175.</a></li><li><a class="nounderline abstract_t">Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358:2127.</a></li><li><a class="nounderline abstract_t">Balami JS, Buchan AM. Complications of intracerebral haemorrhage. Lancet Neurol 2012; 11:101.</a></li><li><a class="nounderline abstract_t">Venkatasubramanian C, Mlynash M, Finley-Caulfield A, et al. Natural history of perihematomal edema after intracerebral hemorrhage measured by serial magnetic resonance imaging. Stroke 2011; 42:73.</a></li><li><a class="nounderline abstract_t">Staykov D, Wagner I, Volbers B, et al. Natural course of perihemorrhagic edema after intracerebral hemorrhage. Stroke 2011; 42:2625.</a></li><li><a class="nounderline abstract_t">Li N, Worthmann H, Heeren M, et al. Temporal pattern of cytotoxic edema in the perihematomal region after intracerebral hemorrhage: a serial magnetic resonance imaging study. Stroke 2013; 44:1144.</a></li><li><a class="nounderline abstract_t">Olivot JM, Mlynash M, Kleinman JT, et al. MRI profile of the perihematomal region in acute intracerebral hemorrhage. Stroke 2010; 41:2681.</a></li><li><a class="nounderline abstract_t">Oeinck M, Neunhoeffer F, Buttler KJ, et al. Dynamic cerebral autoregulation in acute intracerebral hemorrhage. Stroke 2013; 44:2722.</a></li><li><a class="nounderline abstract_t">Murai Y, Ikeda Y, Teramoto A, Tsuji Y. Magnetic resonance imaging-documented extravasation as an indicator of acute hypertensive intracerebral hemorrhage. J Neurosurg 1998; 88:650.</a></li><li><a class="nounderline abstract_t">Aksoy D, Bammer R, Mlynash M, et al. Magnetic resonance imaging profile of blood-brain barrier injury in patients with acute intracerebral hemorrhage. J Am Heart Assoc 2013; 2:e000161.</a></li><li><a class="nounderline abstract_t">Kidwell CS, Burgess R, Menon R, et al. Hyperacute injury marker (HARM) in primary hemorrhage: a distinct form of CNS barrier disruption. Neurology 2011; 77:1725.</a></li><li><a class="nounderline abstract_t">Silvera S, Oppenheim C, Touzé E, et al. Spontaneous intracerebral hematoma on diffusion-weighted images: influence of T2-shine-through and T2-blackout effects. AJNR Am J Neuroradiol 2005; 26:236.</a></li><li><a class="nounderline abstract_t">Menon RS, Burgess RE, Wing JJ, et al. Predictors of highly prevalent brain ischemia in intracerebral hemorrhage. Ann Neurol 2012; 71:199.</a></li><li><a class="nounderline abstract_t">Garg RK, Liebling SM, Maas MB, et al. Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke 2012; 43:67.</a></li><li><a class="nounderline abstract_t">Kang DW, Han MK, Kim HJ, et al. New ischemic lesions coexisting with acute intracerebral hemorrhage. Neurology 2012; 79:848.</a></li><li><a class="nounderline abstract_t">Auriel E, Gurol ME, Ayres A, et al. Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions. Neurology 2012; 79:2335.</a></li><li><a class="nounderline abstract_t">Boulanger M, Schneckenburger R, Join-Lambert C, et al. Diffusion-Weighted Imaging Hyperintensities in Subtypes of Acute Intracerebral Hemorrhage: Meta-Analysis. Stroke 2019; 50:135.</a></li><li><a class="nounderline abstract_t">Prabhakaran S, Naidech AM. Ischemic brain injury after intracerebral hemorrhage: a critical review. Stroke 2012; 43:2258.</a></li><li><a class="nounderline abstract_t">Beslow LA, Licht DJ, Smith SE, et al. Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study. Stroke 2010; 41:313.</a></li><li><a class="nounderline abstract_t">Cordonnier C, Demchuk A, Ziai W, Anderson CS. Intracerebral haemorrhage: current approaches to acute management. Lancet 2018; 392:1257.</a></li><li><a class="nounderline abstract_t">Garcia JH, Ho KL. Pathology of hypertensive arteriopathy. Neurosurg Clin N Am 1992; 3:497.</a></li><li><a class="nounderline abstract_t">Folsom AR, Yatsuya H, Mosley TH Jr, et al. Risk of intraparenchymal hemorrhage with magnetic resonance imaging-defined leukoaraiosis and brain infarcts. Ann Neurol 2012; 71:552.</a></li><li><a class="nounderline abstract_t">Offenbacher H, Fazekas F, Schmidt R, et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol 1996; 17:573.</a></li><li><a class="nounderline abstract_t">Cheng AL, Batool S, McCreary CR, et al. Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke 2013; 44:2782.</a></li><li><a class="nounderline abstract_t">Meretoja A, Strbian D, Putaala J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke 2012; 43:2592.</a></li><li><a class="nounderline abstract_t">Delgado Almandoz JE, Schaefer PW, Goldstein JN, et al. Practical scoring system for the identification of patients with intracerebral hemorrhage at highest risk of harboring an underlying vascular etiology: the Secondary Intracerebral Hemorrhage Score. AJNR Am J Neuroradiol 2010; 31:1653.</a></li><li><a class="nounderline abstract_t">van Asch CJ, Velthuis BK, Greving JP, et al. External validation of the secondary intracerebral hemorrhage score in The Netherlands. Stroke 2013; 44:2904.</a></li><li><a class="nounderline abstract_t">Gross BA, Jankowitz BT, Friedlander RM. Cerebral Intraparenchymal Hemorrhage: A Review. JAMA 2019; 321:1295.</a></li><li><a class="nounderline abstract_t">Mallon D, Doig D, Dixon L, et al. Neuroimaging in Sickle Cell Disease: A Review. J Neuroimaging 2020; 30:725.</a></li><li><a class="nounderline abstract_t">Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 2014; 9:840.</a></li><li><a class="nounderline abstract_t">Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8:355.</a></li><li><a class="nounderline abstract_t">Sacco S, Marini C, Toni D, et al. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke 2009; 40:394.</a></li><li><a class="nounderline abstract_t">Gebel JM, Broderick JP. Intracerebral hemorrhage. Neurol Clin 2000; 18:419.</a></li><li><a class="nounderline abstract_t">Flaherty ML, Woo D, Haverbusch M, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke 2005; 36:934.</a></li><li><a class="nounderline abstract_t">Labovitz DL, Halim A, Boden-Albala B, et al. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology 2005; 65:518.</a></li><li><a class="nounderline abstract_t">van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010; 9:167.</a></li><li><a class="nounderline abstract_t">Poon MT, Bell SM, Al-Shahi Salman R. Epidemiology of Intracerebral Haemorrhage. Front Neurol Neurosci 2015; 37:1.</a></li><li><a class="nounderline abstract_t">Broderick JP, Brott T, Tomsick T, et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993; 78:188.</a></li><li><a class="nounderline abstract_t">Stein M, Misselwitz B, Hamann GF, et al. Intracerebral hemorrhage in the very old: future demographic trends of an aging population. Stroke 2012; 43:1126.</a></li><li><a class="nounderline abstract_t">Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health 2013; 1:e259.</a></li><li><a class="nounderline abstract_t">Bruno A, Carter S, Qualls C, Nolte KB. Incidence of spontaneous intracerebral hemorrhage among Hispanics and non-Hispanic whites in New Mexico. Neurology 1996; 47:405.</a></li><li><a class="nounderline abstract_t">Morgenstern LB, Smith MA, Lisabeth LD, et al. Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol 2004; 160:376.</a></li><li><a class="nounderline abstract_t">Gokhale S, Caplan LR, James ML. Sex differences in incidence, pathophysiology, and outcome of primary intracerebral hemorrhage. Stroke 2015; 46:886.</a></li><li><a class="nounderline abstract_t">Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009; 40:1082.</a></li><li><a class="nounderline abstract_t">Woo D, Sauerbeck LR, Kissela BM, et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke 2002; 33:1190.</a></li><li><a class="nounderline abstract_t">Woo D, Haverbusch M, Sekar P, et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke 2004; 35:1703.</a></li><li><a class="nounderline abstract_t">Feldmann E, Broderick JP, Kernan WN, et al. Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke 2005; 36:1881.</a></li><li><a class="nounderline abstract_t">Zia E, Hedblad B, Pessah-Rasmussen H, et al. Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant. Stroke 2007; 38:2681.</a></li><li><a class="nounderline abstract_t">Martini SR, Flaherty ML, Brown WM, et al. Risk factors for intracerebral hemorrhage differ according to hemorrhage location. Neurology 2012; 79:2275.</a></li><li><a class="nounderline abstract_t">Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 2003; 34:2060.</a></li><li><a class="nounderline abstract_t">Sturgeon JD, Folsom AR, Longstreth WT Jr, et al. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke 2007; 38:2718.</a></li><li><a class="nounderline abstract_t">O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376:112.</a></li><li><a class="nounderline abstract_t">Jackson CA, Sudlow CL. Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? J Neurol Neurosurg Psychiatry 2006; 77:1244.</a></li><li><a class="nounderline abstract_t">Ritter MA, Droste DW, Hegedüs K, et al. Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients. Neurology 2005; 64:1233.</a></li><li><a class="nounderline abstract_t">Arima H, Tzourio C, Anderson C, et al. Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke 2010; 41:394.</a></li><li><a class="nounderline abstract_t">Toyoda K, Yasaka M, Uchiyama S, et al. Blood pressure levels and bleeding events during antithrombotic therapy: the Bleeding with Antithrombotic Therapy (BAT) Study. Stroke 2010; 41:1440.</a></li><li><a class="nounderline abstract_t">Hald SM, Möller S, García Rodríguez LA, et al. Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018. JAMA Netw Open 2021; 4:e218380.</a></li><li><a class="nounderline abstract_t">López-López JA, Sterne JAC, Thom HHZ, et al. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ 2017; 359:j5058.</a></li><li><a class="nounderline abstract_t">Gore JM, Sloan M, Price TR, et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. Circulation 1991; 83:448.</a></li><li><a class="nounderline abstract_t">National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581.</a></li><li><a class="nounderline abstract_t">He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998; 280:1930.</a></li><li><a class="nounderline abstract_t">Hart RG, Halperin JL, McBride R, et al. Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol 2000; 57:326.</a></li><li><a class="nounderline abstract_t">Thrift AG, McNeil JJ, Forbes A, Donnan GA. Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke 1996; 27:2020.</a></li><li><a class="nounderline abstract_t">García-Rodríguez LA, Gaist D, Morton J, et al. Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology 2013; 81:566.</a></li><li><a class="nounderline abstract_t">Gorelick PB, Weisman SM. Risk of hemorrhagic stroke with aspirin use: an update. Stroke 2005; 36:1801.</a></li><li><a class="nounderline abstract_t">ACTIVE Investigators, Connolly SJ, Pogue J, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009; 360:2066.</a></li><li><a class="nounderline abstract_t">Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med 2018; 379:215.</a></li><li><a class="nounderline abstract_t">Thrift AG, McNeil JJ, Forbes A, Donnan GA. Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study. BMJ 1999; 318:759.</a></li><li><a class="nounderline abstract_t">Bak S, Andersen M, Tsiropoulos I, et al. Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study. Stroke 2003; 34:379.</a></li><li><a class="nounderline abstract_t">Johnsen SP, Pedersen L, Friis S, et al. Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study. Stroke 2003; 34:387.</a></li><li><a class="nounderline abstract_t">Choi NK, Park BJ, Jeong SW, et al. Nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke risk: the Acute Brain Bleeding Analysis study. Stroke 2008; 39:845.</a></li><li><a class="nounderline abstract_t">Pezzini A, Grassi M, Paciaroni M, et al. Obesity and the risk of intracerebral hemorrhage: the multicenter study on cerebral hemorrhage in Italy. Stroke 2013; 44:1584.</a></li><li><a class="nounderline abstract_t">Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107:2589.</a></li><li><a class="nounderline abstract_t">Patra J, Taylor B, Irving H, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis. BMC Public Health 2010; 10:258.</a></li><li><a class="nounderline abstract_t">Larsson SC, Wallin A, Wolk A, Markus HS. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med 2016; 14:178.</a></li><li><a class="nounderline abstract_t">Chen CJ, Brown WM, Moomaw CJ, et al. Alcohol use and risk of intracerebral hemorrhage. Neurology 2017; 88:2043.</a></li><li><a class="nounderline abstract_t">Klatsky AL, Gunderson E. Alcohol and hypertension: a review. J Am Soc Hypertens 2008; 2:307.</a></li><li><a class="nounderline abstract_t">Howard G, Cushman M, Howard VJ, et al. Risk factors for intracerebral hemorrhage: the REasons for geographic and racial differences in stroke (REGARDS) study. Stroke 2013; 44:1282.</a></li><li><a class="nounderline abstract_t">Wang X, Dong Y, Qi X, et al. Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke 2013; 44:1833.</a></li><li><a class="nounderline abstract_t">Woo D, Deka R, Falcone GJ, et al. Apolipoprotein E, statins, and risk of intracerebral hemorrhage. Stroke 2013; 44:3013.</a></li><li><a class="nounderline abstract_t">Hackam DG, Woodward M, Newby LK, et al. Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation 2011; 124:2233.</a></li><li><a class="nounderline abstract_t">McKinney JS, Kostis WJ. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke 2012; 43:2149.</a></li><li><a class="nounderline abstract_t">Gaist D, Goldstein LB, Cea Soriano L, García Rodríguez LA. Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack. Stroke 2017; 48:3245.</a></li><li><a class="nounderline abstract_t">Ziff OJ, Banerjee G, Ambler G, Werring DJ. Statins and the risk of intracerebral haemorrhage in patients with stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2019; 90:75.</a></li><li><a class="nounderline abstract_t">Ribe AR, Vestergaard CH, Vestergaard M, et al. Statins and Risk of Intracerebral Hemorrhage in Individuals With a History of Stroke. Stroke 2020; 51:1111.</a></li><li><a class="nounderline abstract_t">Pandit AK, Kumar P, Kumar A, et al. High-dose statin therapy and risk of intracerebral hemorrhage: a meta-analysis. Acta Neurol Scand 2016; 134:22.</a></li><li><a class="nounderline abstract_t">Devan WJ, Falcone GJ, Anderson CD, et al. Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage. Stroke 2013; 44:1578.</a></li><li><a class="nounderline abstract_t">Biffi A, Sonni A, Anderson CD, et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol 2010; 68:934.</a></li><li><a class="nounderline abstract_t">Seiffge DJ, Wilson D, Ambler G, et al. Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants. J Neurol Neurosurg Psychiatry 2021.</a></li><li><a class="nounderline abstract_t">Seiffge DJ, Meinel T, Purrucker JC, et al. Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants. J Neurol Neurosurg Psychiatry 2021; 92:534.</a></li><li><a class="nounderline abstract_t">Kurth T, Kase CS, Berger K, et al. Smoking and the risk of hemorrhagic stroke in men. Stroke 2003; 34:1151.</a></li><li><a class="nounderline abstract_t">Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000; 343:1826.</a></li><li><a class="nounderline abstract_t">Lee SM, Choi NK, Lee BC, et al. Caffeine-containing medicines increase the risk of hemorrhagic stroke. Stroke 2013; 44:2139.</a></li><li><a class="nounderline abstract_t">Behrouz R, Topel CH, Seifi A, et al. Risk of intracerebral hemorrhage in HIV/AIDS: a systematic review and meta-analysis. J Neurovirol 2016; 22:634.</a></li><li><a class="nounderline abstract_t">Tseng CH, Muo CH, Hsu CY, Kao CH. Increased Risk of Intracerebral Hemorrhage Among Patients With Hepatitis C Virus Infection. Medicine (Baltimore) 2015; 94:e2132.</a></li><li><a class="nounderline abstract_t">Karibe H, Niizuma H, Ohyama H, et al. Hepatitis C virus (HCV) infection as a risk factor for spontaneous intracerebral hemorrhage: hospital based case-control study. J Clin Neurosci 2001; 8:423.</a></li><li><a class="nounderline abstract_t">Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology 2013; 81:928.</a></li><li><a class="nounderline abstract_t">Nagel MA, Gilden D. Update on varicella zoster virus vasculopathy. Curr Infect Dis Rep 2014; 16:407.</a></li><li><a class="nounderline abstract_t">Li KY, Chou MC, Wei JC, et al. Newly Diagnosed Leptospirosis and Subsequent Hemorrhagic Stroke: A Nationwide Population-Based Cohort Study. Stroke 2021; 52:913.</a></li><li><a class="nounderline abstract_t">Bos MJ, Koudstaal PJ, Hofman A, Breteler MM. Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study. Stroke 2007; 38:3127.</a></li><li><a class="nounderline abstract_t">Ovbiagele B, Wing JJ, Menon RS, et al. Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage. Stroke 2013; 44:2409.</a></li><li><a class="nounderline abstract_t">Shimizu Y, Maeda K, Imano H, et al. Chronic kidney disease and drinking status in relation to risks of stroke and its subtypes: the Circulatory Risk in Communities Study (CIRCS). Stroke 2011; 42:2531.</a></li><li><a class="nounderline abstract_t">Boulanger M, Poon MT, Wild SH, Al-Shahi Salman R. Association between diabetes mellitus and the occurrence and outcome of intracerebral hemorrhage. Neurology 2016; 87:870.</a></li><li><a class="nounderline abstract_t">Hackam DG, Mrkobrada M. Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 2012; 79:1862.</a></li><li><a class="nounderline abstract_t">Liu L, Fuller M, Behymer TP, et al. Selective Serotonin Reuptake Inhibitors and Intracerebral Hemorrhage Risk and Outcome. Stroke 2020; 51:1135.</a></li><li><a class="nounderline abstract_t">Sacco S, Ornello R, Ripa P, et al. Migraine and hemorrhagic stroke: a meta-analysis. Stroke 2013; 44:3032.</a></li><li><a class="nounderline abstract_t">Chen D, Zhang C, Parikh N, et al. Association Between Systemic Amyloidosis and Intracranial Hemorrhage. Stroke 2022; 53:e92.</a></li><li><a class="nounderline abstract_t">van Etten ES, Kaushik K, Jolink WMT, et al. Trigger Factors for Spontaneous Intracerebral Hemorrhage: A Case-Crossover Study. Stroke 2022; 53:1692.</a></li><li class="breakAll">Stroke pathophysiology, diagnosis, and management, Barnett HJ, Mohr JP, Stein BM (Eds), Churchill Livingstone, Philadelphia 1998.</li><li><a class="nounderline abstract_t">Delcourt C, Sato S, Zhang S, et al. Intracerebral hemorrhage location and outcome among INTERACT2 participants. Neurology 2017; 88:1408.</a></li><li><a class="nounderline abstract_t">Fuh JL, Wang SJ. Caudate hemorrhage: clinical features, neuropsychological assessments and radiological findings. Clin Neurol Neurosurg 1995; 97:296.</a></li><li><a class="nounderline abstract_t">Chung CS, Caplan LR, Yamamoto Y, et al. Striatocapsular haemorrhage. Brain 2000; 123 ( Pt 9):1850.</a></li><li><a class="nounderline abstract_t">De Herdt V, Dumont F, Hénon H, et al. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology 2011; 77:1794.</a></li><li><a class="nounderline abstract_t">Beghi E, D'Alessandro R, Beretta S, et al. Incidence and predictors of acute symptomatic seizures after stroke. Neurology 2011; 77:1785.</a></li><li><a class="nounderline abstract_t">Faught E, Peters D, Bartolucci A, et al. Seizures after primary intracerebral hemorrhage. Neurology 1989; 39:1089.</a></li><li><a class="nounderline abstract_t">Passero S, Rocchi R, Rossi S, et al. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 2002; 43:1175.</a></li><li><a class="nounderline abstract_t">Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003; 60:1441.</a></li><li><a class="nounderline abstract_t">Kuramatsu JB, Sauer R, Mauer C, et al. Correlation of age and haematoma volume in patients with spontaneous lobar intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 2011; 82:144.</a></li><li><a class="nounderline abstract_t">Lele A, Lakireddy V, Gorbachov S, et al. A Narrative Review of Cardiovascular Abnormalities After Spontaneous Intracerebral Hemorrhage. J Neurosurg Anesthesiol 2019; 31:199.</a></li><li><a class="nounderline abstract_t">Pinnamaneni S, Aronow WS, Frishman WH. Neurocardiac Injury After Cerebral and Subarachnoid Hemorrhages. Cardiol Rev 2017; 25:89.</a></li><li><a class="nounderline abstract_t">Davis AM, Natelson BH. Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death. Tex Heart Inst J 1993; 20:158.</a></li><li><a class="nounderline abstract_t">Kidwell CS, Wintermark M. Imaging of intracranial haemorrhage. Lancet Neurol 2008; 7:256.</a></li><li><a class="nounderline abstract_t">Wong GK, Siu DY, Abrigo JM, et al. Computed tomographic angiography and venography for young or nonhypertensive patients with acute spontaneous intracerebral hemorrhage. Stroke 2011; 42:211.</a></li><li><a class="nounderline abstract_t">Phan TG, Krishnadas N, Lai VWY, et al. Meta-Analysis of Accuracy of the Spot Sign for Predicting Hematoma Growth and Clinical Outcomes. Stroke 2019; 50:2030.</a></li><li><a class="nounderline abstract_t">Fiebach JB, Schellinger PD, Gass A, et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 2004; 35:502.</a></li><li><a class="nounderline abstract_t">Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004; 292:1823.</a></li><li><a class="nounderline abstract_t">Rixe J, Conradi G, Rolf A, et al. Radiation dose exposure of computed tomography coronary angiography: comparison of dual-source, 16-slice and 64-slice CT. Heart 2009; 95:1337.</a></li><li><a class="nounderline abstract_t">Thulborn KR. My starting point: the discovery of an NMR method for measuring blood oxygenation using the transverse relaxation time of blood water. Neuroimage 2012; 62:589.</a></li><li><a class="nounderline abstract_t">Patel MR, Edelman RR, Warach S. Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke 1996; 27:2321.</a></li><li><a class="nounderline abstract_t">Linfante I, Llinas RH, Caplan LR, Warach S. MRI features of intracerebral hemorrhage within 2 hours from symptom onset. Stroke 1999; 30:2263.</a></li><li><a class="nounderline abstract_t">Edelman RR, Johnson K, Buxton R, et al. MR of hemorrhage: a new approach. AJNR Am J Neuroradiol 1986; 7:751.</a></li><li><a class="nounderline abstract_t">Schellinger PD, Jansen O, Fiebach JB, et al. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke 1999; 30:765.</a></li><li><a class="nounderline abstract_t">Kidwell CS, Saver JL, Mattiello J, et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology 2001; 57:1611.</a></li><li><a class="nounderline abstract_t">Shi K, Tian DC, Li ZG, et al. Global brain inflammation in stroke. Lancet Neurol 2019; 18:1058.</a></li><li><a class="nounderline abstract_t">Chen Y, Chen S, Chang J, et al. Perihematomal Edema After Intracerebral Hemorrhage: An Update on Pathogenesis, Risk Factors, and Therapeutic Advances. Front Immunol 2021; 12:740632.</a></li><li><a class="nounderline abstract_t">Posener S, Hmeydia G, Benzakoun J, et al. Remote Diffusion-Weighted Imaging Lesions and Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. Stroke 2023; 54:e133.</a></li><li><a class="nounderline abstract_t">Xu X, Peng S, Zhou Y, et al. Remote diffusion-weighted imaging lesions and blood pressure variability in primary intracerebral hemorrhage. Front Neurol 2022; 13:950056.</a></li><li><a class="nounderline abstract_t">Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996; 27:1304.</a></li><li><a class="nounderline abstract_t">Beslow LA, Ichord RN, Kasner SE, et al. ABC/XYZ estimates intracerebral hemorrhage volume as a percent of total brain volume in children. Stroke 2010; 41:691.</a></li><li><a class="nounderline abstract_t">Broderick JP, Brott TG, Tomsick T, et al. Ultra-early evaluation of intracerebral hemorrhage. J Neurosurg 1990; 72:195.</a></li><li><a class="nounderline abstract_t">Morotti A, Boulouis G, Charidimou A, et al. Hematoma Expansion in Intracerebral Hemorrhage With Unclear Onset. Neurology 2021; 96:e2363.</a></li><li><a class="nounderline abstract_t">Al-Shahi Salman R, Frantzias J, Lee RJ, et al. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. Lancet Neurol 2018; 17:885.</a></li><li><a class="nounderline abstract_t">Wada R, Aviv RI, Fox AJ, et al. CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke 2007; 38:1257.</a></li><li><a class="nounderline abstract_t">Brouwers HB, Goldstein JN, Romero JM, Rosand J. Clinical applications of the computed tomography angiography spot sign in acute intracerebral hemorrhage: a review. Stroke 2012; 43:3427.</a></li><li><a class="nounderline abstract_t">Delgado Almandoz JE, Yoo AJ, Stone MJ, et al. Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score. Stroke 2009; 40:2994.</a></li><li><a class="nounderline abstract_t">Ederies A, Demchuk A, Chia T, et al. Postcontrast CT extravasation is associated with hematoma expansion in CTA spot negative patients. Stroke 2009; 40:1672.</a></li><li><a class="nounderline abstract_t">Schindlbeck KA, Santaella A, Galinovic I, et al. Spot Sign in Acute Intracerebral Hemorrhage in Dynamic T1-Weighted Magnetic Resonance Imaging. Stroke 2016; 47:417.</a></li><li><a class="nounderline abstract_t">Khan Z, Nattanmai P, George P, Newey CR. Spot Sign in Acute Intracerebral Hemorrhage in Magnetic Resonance Imaging: A Case Report and Review of the Literature. Neurologist 2018; 23:104.</a></li><li><a class="nounderline abstract_t">Huynh TJ, Demchuk AM, Dowlatshahi D, et al. Spot sign number is the most important spot sign characteristic for predicting hematoma expansion using first-pass computed tomography angiography: analysis from the PREDICT study. Stroke 2013; 44:972.</a></li><li><a class="nounderline abstract_t">Romero JM, Brouwers HB, Lu J, et al. Prospective validation of the computed tomographic angiography spot sign score for intracerebral hemorrhage. Stroke 2013; 44:3097.</a></li><li><a class="nounderline abstract_t">Ng D, Churilov L, Mitchell P, et al. The CT Swirl Sign Is Associated with Hematoma Expansion in Intracerebral Hemorrhage. AJNR Am J Neuroradiol 2018; 39:232.</a></li><li><a class="nounderline abstract_t">Jain A, Malhotra A, Payabvash S. Imaging of Spontaneous Intracerebral Hemorrhage. Neuroimaging Clin N Am 2021; 31:193.</a></li><li><a class="nounderline abstract_t">Morotti A, Arba F, Boulouis G, Charidimou A. Noncontrast CT markers of intracerebral hemorrhage expansion and poor outcome: A meta-analysis. Neurology 2020; 95:632.</a></li><li><a class="nounderline abstract_t">Morotti A, Poli L, Leuci E, et al. Subarachnoid Extension Predicts Lobar Intracerebral Hemorrhage Expansion. Stroke 2020; 51:1470.</a></li><li><a class="nounderline abstract_t">Hanley DF. Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke 2009; 40:1533.</a></li><li><a class="nounderline abstract_t">Nyquist P, Hanley DF. The use of intraventricular thrombolytics in intraventricular hemorrhage. J Neurol Sci 2007; 261:84.</a></li><li><a class="nounderline abstract_t">Maas MB, Nemeth AJ, Rosenberg NF, et al. Delayed intraventricular hemorrhage is common and worsens outcomes in intracerebral hemorrhage. Neurology 2013; 80:1295.</a></li><li><a class="nounderline abstract_t">Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. Stroke Vasc Neurol 2017; 2:21.</a></li><li><a class="nounderline abstract_t">Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke 2022; 53:e282.</a></li><li><a class="nounderline abstract_t">Loggini A, Mansour A, El Ammar F, et al. Inversion of T Waves on Admission is Associated with Mortality in Spontaneous Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis 2021; 30:105776.</a></li><li><a class="nounderline abstract_t">Wittstock M, Meyer K, Klinke J, et al. Effects of insular involvement on functional outcome after intracerebral hemorrhage. Acta Neurol Scand 2021; 144:559.</a></li><li><a class="nounderline abstract_t">Tung GA, Julius BD, Rogg JM. MRI of intracerebral hematoma: value of vasogenic edema ratio for predicting the cause. Neuroradiology 2003; 45:357.</a></li><li><a class="nounderline abstract_t">Oleinik A, Romero JM, Schwab K, et al. CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke 2009; 40:2393.</a></li></ol></div><div id="topicVersionRevision">Topic 1133 Version 40.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8437667" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Pathophysiology of brain swelling after acute experimental brain compression and decompression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8996478" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Early hemorrhage growth in patients with intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15728810" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Recombinant activated factor VII for acute intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16636233" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18480205" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22172625" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Complications of intracerebral haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21164136" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Natural history of perihematomal edema after intracerebral hemorrhage measured by serial magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21737803" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Natural course of perihemorrhagic edema after intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23391767" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Temporal pattern of cytotoxic edema in the perihematomal region after intracerebral hemorrhage: a serial magnetic resonance imaging study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20947849" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : MRI profile of the perihematomal region in acute intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23943213" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Dynamic cerebral autoregulation in acute intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9525710" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Magnetic resonance imaging-documented extravasation as an indicator of acute hypertensive intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23709564" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Magnetic resonance imaging profile of blood-brain barrier injury in patients with acute intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22031531" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Hyperacute injury marker (HARM) in primary hemorrhage: a distinct form of CNS barrier disruption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15709118" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Spontaneous intracerebral hematoma on diffusion-weighted images: influence of T2-shine-through and T2-blackout effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22367992" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Predictors of highly prevalent brain ischemia in intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21980211" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22843271" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : New ischemic lesions coexisting with acute intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23197745" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30580720" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Diffusion-Weighted Imaging Hyperintensities in Subtypes of Acute Intracerebral Hemorrhage: Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22821611" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Ischemic brain injury after intracerebral hemorrhage: a critical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20019325" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30319113" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Intracerebral haemorrhage: current approaches to acute management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1633473" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pathology of hypertensive arteriopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22522444" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Risk of intraparenchymal hemorrhage with magnetic resonance imaging-defined leukoaraiosis and brain infarcts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8881257" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : MR of cerebral abnormalities concomitant with primary intracerebral hematomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23920014" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22858729" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20581068" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Practical scoring system for the identification of patients with intracerebral hemorrhage at highest risk of harboring an underlying vascular etiology: the Secondary Intracerebral Hemorrhage Score.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23920015" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : External validation of the secondary intracerebral hemorrhage score in The Netherlands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30938800" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Cerebral Intraparenchymal Hemorrhage: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33463866" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Neuroimaging in Sickle Cell Disease: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25156220" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19233729" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19038914" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10757834" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15790947" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Racial variations in location and risk of intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16116109" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20056489" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26588164" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Epidemiology of Intracerebral Haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8421201" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22282880" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Intracerebral hemorrhage in the very old: future demographic trends of an aging population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25104492" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8757012" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Incidence of spontaneous intracerebral hemorrhage among Hispanics and non-Hispanic whites in New Mexico.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15286023" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25657181" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Sex differences in incidence, pathophysiology, and outcome of primary intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19211488" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Sex differences in stroke epidemiology: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11988589" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15155969" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Effect of untreated hypertension on hemorrhagic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16081867" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Major risk factors for intracerebral hemorrhage in the young are modifiable.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17761929" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23175721" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Risk factors for intracerebral hemorrhage differ according to hemorrhage location.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12843354" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Risk factors for intracerebral hemorrhage in the general population: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17761915" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Risk factors for intracerebral hemorrhage in a pooled prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20561675" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16690694" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15824353" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20044530" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20489173" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Blood pressure levels and bleeding events during antithrombotic therapy: the Bleeding with Antithrombotic Therapy (BAT) Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33950207" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29183961" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1899364" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7477192" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Tissue plasminogen activator for acute ischemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9851479" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10714657" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8898809" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23843464" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Antithrombotic drugs and risk of hemorrhagic stroke in the general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16020759" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Risk of hemorrhagic stroke with aspirin use: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19336502" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Effect of clopidogrel added to aspirin in patients with atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29766750" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10082697" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12574546" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12574547" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18258834" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke risk: the Acute Brain Bleeding Analysis study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23549133" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Obesity and the risk of intracerebral hemorrhage: the multicenter study on cerebral hemorrhage in Italy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12743002" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Obstructive sleep apnea and the recurrence of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20482788" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27881167" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28446657" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Alcohol use and risk of intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20409912" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Alcohol and hypertension: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23532012" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Risk factors for intracerebral hemorrhage: the REasons for geographic and racial differences in stroke (REGARDS) study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23704101" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24008570" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Apolipoprotein E, statins, and risk of intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22007076" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22588266" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29070714" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30150320" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Statins and the risk of intracerebral haemorrhage in patients with stroke: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32114928" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Statins and Risk of Intracerebral Hemorrhage in Individuals With a History of Stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26647879" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : High-dose statin therapy and risk of intracerebral hemorrhage: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23559261" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21061402" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Variants at APOE influence risk of deep and lobar intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33741739" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33542084" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12663877" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Smoking and the risk of hemorrhagic stroke in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11117973" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Phenylpropanolamine and the risk of hemorrhagic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23743970" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Caffeine-containing medicines increase the risk of hemorrhagic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27044037" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Risk of intracerebral hemorrhage in HIV/AIDS: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26579831" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Increased Risk of Intracerebral Hemorrhage Among Patients With Hepatitis C Virus Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11535009" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Hepatitis C virus (HCV) infection as a risk factor for spontaneous intracerebral hemorrhage: hospital based case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23999562" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : The global epidemiology of herpes zoster.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24819870" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Update on varicella zoster virus vasculopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33494640" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Newly Diagnosed Leptospirosis and Subsequent Hemorrhagic Stroke: A Nationwide Population-Based Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17962600" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23847251" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21852604" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Chronic kidney disease and drinking status in relation to risks of stroke and its subtypes: the Circulatory Risk in Communities Study (CIRCS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27473136" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Association between diabetes mellitus and the occurrence and outcome of intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23077009" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32126942" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Selective Serotonin Reuptake Inhibitors and Intracerebral Hemorrhage Risk and Outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24085027" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Migraine and hemorrhagic stroke: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35109677" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Association Between Systemic Amyloidosis and Intracranial Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34911344" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Trigger Factors for Spontaneous Intracerebral Hemorrhage: A Case-Crossover Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34911344" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Trigger Factors for Spontaneous Intracerebral Hemorrhage: A Case-Crossover Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28235817" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Intracerebral hemorrhage location and outcome among INTERACT2 participants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8599895" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Caudate hemorrhage: clinical features, neuropsychological assessments and radiological findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10960049" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Striatocapsular haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21975203" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21975208" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Incidence and predictors of acute symptomatic seizures after stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2761703" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Seizures after primary intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12366733" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Seizures after spontaneous supratentorial intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12743228" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20667864" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Correlation of age and haematoma volume in patients with spontaneous lobar intracerebral haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29389729" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : A Narrative Review of Cardiovascular Abnormalities After Spontaneous Intracerebral Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27465536" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Neurocardiac Injury After Cerebral and Subarachnoid Hemorrhages.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8219819" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18275927" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Imaging of intracranial haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21088241" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Computed tomographic angiography and venography for young or nonhypertensive patients with acute spontaneous intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31272327" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Meta-Analysis of Accuracy of the Spot Sign for Predicting Hematoma Growth and Clinical Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14739410" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15494579" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Comparison of MRI and CT for detection of acute intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19482842" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Radiation dose exposure of computed tomography coronary angiography: comparison of dual-source, 16-slice and 64-slice CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22001265" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : My starting point: the discovery of an NMR method for measuring blood oxygenation using the transverse relaxation time of blood water.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8969800" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10548654" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : MRI features of intracerebral hemorrhage within 2 hours from symptom onset.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3096097" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : MR of hemorrhage: a new approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10187876" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11706101" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31296369" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Global brain inflammation in stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34737745" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Perihematomal Edema After Intracerebral Hemorrhage: An Update on Pathogenesis, Risk Factors, and Therapeutic Advances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36866676" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Remote Diffusion-Weighted Imaging Lesions and Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36203972" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Remote diffusion-weighted imaging lesions and blood pressure variability in primary intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8711791" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : The ABCs of measuring intracerebral hemorrhage volumes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20181678" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : ABC/XYZ estimates intracerebral hemorrhage volume as a percent of total brain volume in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2295917" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Ultra-early evaluation of intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33795389" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Hematoma Expansion in Intracerebral Hemorrhage With Unclear Onset.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30120039" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17322083" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23132779" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Clinical applications of the computed tomography angiography spot sign in acute intracerebral hemorrhage: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19574553" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19286577" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Postcontrast CT extravasation is associated with hematoma expansion in CTA spot negative patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26715459" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Spot Sign in Acute Intracerebral Hemorrhage in Dynamic T1-Weighted Magnetic Resonance Imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29722746" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Spot Sign in Acute Intracerebral Hemorrhage in Magnetic Resonance Imaging: A Case Report and Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23444309" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Spot sign number is the most important spot sign characteristic for predicting hematoma expansion using first-pass computed tomography angiography: analysis from the PREDICT study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24021687" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Prospective validation of the computed tomographic angiography spot sign score for intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29217744" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : The CT Swirl Sign Is Associated with Hematoma Expansion in Intracerebral Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33902874" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Imaging of Spontaneous Intracerebral Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32847959" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Noncontrast CT markers of intracerebral hemorrhage expansion and poor outcome: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32200757" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Subarachnoid Extension Predicts Lobar Intracerebral Hemorrhage Expansion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19246695" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17553525" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : The use of intraventricular thrombolytics in intraventricular hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23516315" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Delayed intraventricular hemorrhage is common and worsens outcomes in intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28959487" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Current management of spontaneous intracerebral haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35579034" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33839377" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Inversion of T Waves on Admission is Associated with Mortality in Spontaneous Intracerebral Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34224142" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Effects of insular involvement on functional outcome after intracerebral hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12736768" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : MRI of intracerebral hematoma: value of vasogenic edema ratio for predicting the cause.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19461032" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
